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Resumo
As doenças cerebrovasculares são uma das principais causas de morte e incapacidade em
todo o mundo. Em 2015, mais de 590.000 pacientes foram hospitalizados por estas doen-
ças no Brasil, com aproximadamente 100.000 óbitos. A prevenção de danos secundários
é um dos principais objetivos no tratamento de doenças cerebrovasculares graves, como
o acidente vascular cerebral (AVC). No entanto, atualmente há uma falta de métodos
não invasivos para monitoramento contínuo da fisiologia cerebral. Neste contexto, a es-
pectroscopia óptica de difusão (DOS) e a espectroscopia de correlação de difusão (DCS)
foram recentemente propostas como potenciais monitores não invasivos e contínuos capa-
zes de fornecer informações neurofisiológicas em pacientes neurocríticos. Ao incidir luz
infravermelha no escalpo, DCS pode medir o fluxo sanguíneo cerebral (CBF) e DOS pode
medir as concentrações de oxi e desoxi-hemoglobina. A combinação de DOS e DCS foi
explorada anteriormente para monitorar pacientes em vários cenários clínicos, como mo-
nitoramento neonatal, durante intervenções cerebrovasculares e para monitoramento de
pacientes neurocríticos. No entanto, a confiabilidade da técnica para fornecer informações
precisas em tempo real durante medições longitudinais, bem como durante alguns tipos
de intervenções clínicas, permanece em grande parte não estudada.
O principal objetivo desta tese foi mostrar que as técnicas de óptica de difusão podem
auxiliar de maneira confiável e no monitoramento em tempo real de doenças cerebrovas-
culares. Para isso, desenvolvemos sistemas baseados em óptica de difusão e testamos a
viabilidade destes sistemas em diferentes ambientes clínicos, envolvendo o monitoramento
de pacientes dentro de uma unidade de terapia intensiva (UTI), bem como durante o
tratamento endovascular de AVC. Primeiro, relatamos a construção e a translação de
um sistema híbrido de óptica de difusão, combinando DOS e DCS, para o monitora-
mento em tempo real da fisiologia cerebral de pacientes internados em uma UTI. Mais
especificamente, apresentamos dois estudos de caso, onde mostramos que os parâmetros
neurofisiológicos medidos pelas técnicas de óptica de difusão são consistentes com a evo-
lução clínica destes pacientes. Em seguida, relatamos a translação das técnicas de óptica
de difusão para monitorar a hemodinâmicas cerebral durante o tratamento endovascular
de dois pacientes com oclusões na artéria carótida interna. Nossos resultados identifica-
ram um aumento induzido pela recanalização no CBF ipsilateral, com pouca ou nenhuma
alteração no CBF contralateral e no fluxo sanguíneo extracerebral. Nossos resultados
mostraram que a óptica de difusão tem grande potencial para monitorar os danos secun-
dários em pacientes neurocríticos, sem interferir com práticas clínicas. Além disso, nossos
resultados sugerem que o monitoramento hemodinâmico cerebral com as técnicas ópticas
tem potencial para guiar terapias baseadas na fisiologia individual de pacientes. Por fim,
para melhorar a confiabilidade das técnicas de ópticas de difusão, também propusemos
a implementação de algoritmos aprimorados para a análise de dados. Mostramos que,
usando um modelo de duas camadas para DOS/DCS, podemos melhorar a precisão na
recuperação das alterações hemodinâmicas cerebrais.
Palavras-chave: Espectroscopia ótica de difusão; Espectroscopia de correlação de di-
fusão; Fluxo sanguíneo cerebral; Transtornos cerebrovasculares; Tratamento endovascular
Abstract
Cerebrovascular diseases are one of the main causes of death and disability worldwide. In
2015, there were more than 590.000 patients hospitalized due to cerebrovascular diseases
in Brazil, with approximately 100.000 deaths. Prevention of secondary damage is an im-
portant goal in the treatment of severe neurological conditions, such as head trauma and
stroke. However, there is currently a lack of non-invasive methods for continuous monitor-
ing of cerebral physiology in real-time. More recently, diffuse optical spectroscopy (DOS)
and diffuse correlation spectroscopy (DCS) have been proposed as noninvasive and contin-
uous bedside monitors capable of providing neurophysiology information in neurocritical
patients. By shining near-infrared light from the scalp, DCS can measure microvascular
cerebral blood flow (CBF), and DOS can measure oxy- and deoxy-hemoglobin concen-
trations. The combination of DOS and DCS has been previously explored to monitor
patients in several clinical scenarios, such as neonatal monitoring, during cerebrovascular
interventions, and for monitoring of neurocritical patients. However, the reliability of the
technique to provide accurate real-time information during longitudinal (i.e., across mul-
tiple days) measurement as well as during a few different clinical interventions remains
largely unaddressed.
The main goal of this thesis was to show that diffuse optics can reliably aid in mon-
itoring cerebrovascular diseases, in real-time. To that end, we have translated a diffuse
optical system to different clinic environments: during long-term monitoring of patients
inside an intensive care unit, as well as during an endovascular treatment of stroke. First,
we reported the construction and translation of a hybrid diffuse optical system combin-
ing DOS and DCS for real-time monitoring of cerebral physiology in a neuro intensive
care unit. By presenting two representative case-studies, we show that the neurophys-
iological parameters measured by diffuse optics at the bedside are consistent with the
clinical evolution of the patients. Then, we reported the translation of diffuse optics to
monitor frontal-lobe cerebral hemodynamic changes during endovascular treatment of two
patients with ischemic stroke due to internal carotid artery occlusions. The monitoring
instrument identified a recanalization-induced increase in ipsilateral CBF with little or
no concurrent change in contralateral CBF and extracerebral blood flow. Taken together,
our results showed that diffuse optics holds promise for monitoring secondary damage
in neurocritical patients, with minimal interference with current clinical practices. Ad-
ditionally, our results suggest that cerebral hemodynamic monitoring with diffuse optics
has the potential to guide therapy based on the individual physiology of neurocritical
patients. Last, to improve the reliability of the diffuse optical techniques, we have also
proposed the implementation of improved algorithms for data analysis. We showed that
by using a two-layer model for DOS/DCS, we can improve the accuracy of diffuse optics
in recovering the cerebral hemodynamic changes.
Keywords: Diffuse optical spectroscopy; Diffuse correlation spectroscopy; Cerebral
blood flow; Cerebrovascular disorders; Endovascular treatment
List of Figures
2.1 Pictorial representation of the average path of the detected photons . . . . 18
2.2 Representation of a semi-infinite medium in the extrapolated boundary
condition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.3 Representative signals from the three different DOS techniques. . . . . . . 26
2.4 Extinction coefficients of the main components of human tissue. . . . . . . 27
3.1 Instrumentation utilized for the study inside a intensive care unit. . . . . . 43
3.2 Real-time graphical user interface (GUI) for the developed diffuse optical
system. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.3 Evolution of the brain lesion in a 62 years old female patient following a
high-grade aneurysmal subarachnoid hemorrhage (aSAH). . . . . . . . . . 47
3.4 Temporal evolution of the laterality index for the optically derived physi-
ological parameters in a 62 years old female patient following a high-grade
aneurysmal subarachnoid hemorrhage (aSAH). . . . . . . . . . . . . . . . . 48
3.5 Neurophysiological information of a severe ischemic stroke patient, at the
thirteenth day after hospitalization. . . . . . . . . . . . . . . . . . . . . . . 49
4.1 Schematic of the experimental setup for monitoring mechanical thrombec-
tomy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4.2 Instrumentation used to measure the cerebral hemodynamics of patients
during mechanical thrombectomy. . . . . . . . . . . . . . . . . . . . . . . . 58
4.3 Imaging before and after mechanical thrombectomy (Patient 1). . . . . . . 61
4.4 Hemodynamics of recanalization (Patient 1). . . . . . . . . . . . . . . . . . 62
4.5 Imaging before and after mechanical thrombectomy (Patient 2). . . . . . . 63
4.6 Hemodynamics of recanalization (Patient 2). . . . . . . . . . . . . . . . . . 64
4.7 CBF heart-rate pulsatility during mechanical thrombectomy. . . . . . . . . 65
5.1 Pictorial representation of the two-layer geometry. . . . . . . . . . . . . . . 72
5.2 Experimental setup for the phantom measurements. . . . . . . . . . . . . 76
5.3 Results of the forward model simulations. . . . . . . . . . . . . . . . . . . . 77
5.4 Theoretical amplitude and phase values simulated for source-detector sep-
arations between 0.8 and 4.6cm. . . . . . . . . . . . . . . . . . . . . . . . . 78
5.5 Results of the NIRFAST simulations with the shorter set of source-detector
separations (ρShort). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
5.6 Results of the NIRFAST simulations with the longer set of source-detector
separations (ρLong). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5.7 Optical coefficients recovered from the two-layer phantom experiment. . . . 81
5.8 Flow recovered from the two-layer phantom experiment using a two-layer
model for DCS, and a SI model for FD-DOS. . . . . . . . . . . . . . . . . . 82
5.9 Flow recovered using the two-layer model for both DCS and FD-DOS. . . . 83
List of Tables
4.1 Baseline, procedural, and outcome summary. . . . . . . . . . . . . . . . . . 60
A.1 Description of the Hunt & Hess grade scale and associated mortality rate
[148]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
A.2 Description of the Fisher grade scale and associated risk of vasospasm [149]. 87
A.3 National Institute of Health Stroke Scale (NIHSS) scores and associated
stroke severity [150]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
A.4 Modified treatment in cerebral ischemia scale grade definition (mTICI)
[175, 176]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
List of Abbreviations
ABP Arterial blood pressure
APD Avalanche photodiode
aSAH Aneurysmal subarachnoid hemorrhage
BFI Blood flow index
CBF Cerebral blood flow
CBFv Cerebral blood flow velocity
CBV Cerebral blood volume
CMRO2 Cerebral metabolic rate of oxygen
CT Computed tomography
CTE Correlation transport equation
CW Continuous-wave
DCS Diffuse correlation spectroscopy
DOS Diffuse optical spectroscopy
DOT Diffuse optical tomography
DTOF Distribution of time of flight
EEG Electroencephalography
FD Frequency-domain
FWHM Full width at half maximum
GUI Graphical user interface
HbO Oxyhemoglobin
HbR Deoxyhemoglobin
HbT Total hemoglobin
Hgb Hemoglobin concentration in blood
ICA Internal carotid artery
ICG Indocyanine green
ICP Intracranial pressure
ICU Intensive care unit
IRF Instrument response function
LI Laterality index
MAP Mean arterial pressure
MBLL Modified Beer-Lambert law
MCA Middle-cerebral artery
MRI Magnetic ressonance imaging
mTICI Modified treatment in cerebral ischemia
NIHSS National institute of health stroke scale
NIR Near infrared
NIRS Near-infrared spectroscopy
OEF Oxygen extraction fraction
PET Positron emission tomography
PFC Pre-frontal cortex
PMT Photo-multiplier tube
RBC Red blood cell
rCBF Relative cerebral blood flow
RTE Radiative transport equation
SaO2 Arterial oxygen saturation
SI Semi-infinite
SNR Signal-to-noise ratio
SPAD Single photon avalanche photodiode
StO2 Oxygen saturation
TCD Transcranial doppler ultrasound
TCSPC Time-correlated single photon counting
TD Time-domain
Contents
1 Introduction 15
2 Principles of Diffuse Optics 18
2.1 Theoretical aspects of diffuse optics . . . . . . . . . . . . . . . . . . . . . . 19
2.1.1 Diffuse Optical Spectroscopy . . . . . . . . . . . . . . . . . . . . . . 19
2.1.2 Diffuse Correlation Spectroscopy . . . . . . . . . . . . . . . . . . . 23
2.2 Experimental methods of diffuse optics . . . . . . . . . . . . . . . . . . . . 25
2.2.1 Diffuse Optical Spectroscopy . . . . . . . . . . . . . . . . . . . . . . 25
2.2.2 Diffuse Correlation Spectroscopy . . . . . . . . . . . . . . . . . . . 34
3 Real-time assessment of cerebral hemodynamics with diffuse optical
spectroscopies in a neuro intensive care unit 40
3.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.1.1 Subject recruitment . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.1.2 Experimental protocol . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.1.3 Optical instrumentation . . . . . . . . . . . . . . . . . . . . . . . . 42
3.1.4 Optical analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.2.1 Cerebral hemodynamics of a subarachnoid hemorrhage patient mon-
itored during hospitalization . . . . . . . . . . . . . . . . . . . . . . 45
3.2.2 Cerebral hemodynamics of a severe ischemic stroke patient . . . . . 48
3.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.4 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4 Cerebral optical monitoring of endovascular treatment of stroke 54
4.1 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.1.1 Subject recruitment . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.1.2 Experimental protocol . . . . . . . . . . . . . . . . . . . . . . . . . 56
4.1.3 Optical instrumentation . . . . . . . . . . . . . . . . . . . . . . . . 56
4.1.4 Optical analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
5 Improvement of the optical parameters recovered from diffuse optical
spectroscopies 70
5.1 The two-layer model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.2.1 The fitting algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.2.2 Forward-model simulations . . . . . . . . . . . . . . . . . . . . . . . 74
5.2.3 Simulation using a finite-elements package . . . . . . . . . . . . . . 74
5.2.4 Phantom measurements . . . . . . . . . . . . . . . . . . . . . . . . 74
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
5.3.1 Forward-model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
5.3.2 Simulation using a finite-elements package . . . . . . . . . . . . . . 78
5.3.3 Phantom experiments . . . . . . . . . . . . . . . . . . . . . . . . . 81
5.4 Discussion and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . 83
6 Summary and Perspectives 85
A Description of the clinical scales 87
B Ethics committee approval letter 89
C Consent forms 93
Bibliography 97
15
Chapter 1
Introduction
Cerebrovascular diseases are one of the main causes of death and disability worldwide.
In 2015 alone, there were more than 590.000 patients hospitalized due to cerebrovascular
diseases in Brazil, such as stroke, with approximately 140.000 deaths [1]. The prevalence
of cerebrovascular diseases is age-dependent, and since the life expectancy is increasing,
the global burden and prevalence of cerebrovascular diseases will also increase, with a
disproportionate increase likely in low- and middle-income countries.
One of the main goals in the care of patients with severe cerebrovascular injury is to
prevent secondary damage. Additional insults following the primary damage affect and
may be affected by both systemic (e.g., arterial blood pressure, ABP) and cerebral phys-
iologies (e.g., cerebral blood flow, cerebral metabolism and cerebral oxygenation) [2–5].
To this end, close patient monitoring following acute brain lesions is essential to prevent
secondary damage, and it may directly improve mortality and morbidity rates [6–8]. How-
ever, continuous cerebral monitoring often requires invasive catheters that measure brain
parenchymal vascular physiology [6]. These devices, however, are typically very expensive
and only provide data from a single subcortical location. They are also impractical for
hyperacute stroke due to both the time required to place them and the risk of tissue
injury and/or hemorrhage, particularly in patients treated with intravenous thrombolysis
or antithrombotic medications. Furthermore, due to its invasiveness, continuous cerebral
monitoring has only been employed in a few, more severe cases, and it is seldom available
in low-budget environments. Less invasive brain imaging techniques, such as computed
tomography (CT) and magnetic resonance imaging (MRI), may provide quantification
of the cerebral physiology, but these diagnostics usually require transport to an imaging
suite, utilize exogenous contrast agents, and/or generally offer only snapshots in time.
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Among the few potential noninvasive techniques to probe brain physiology at the
patient’s bedside, Transcranial Doppler ultrasound (TCD) is generally used to monitor
cerebral blood flow velocity (CBFv) in the large arteries [9]. However, TCD is operator-
dependent, not suitable for long-term monitoring, and is not sensitive to changes at the
microvasculature. Additionally, placement of TCD probes requires a skilled operator, and
approximately 10% of the population do not have adequate temporal insonation windows
[10, 11]. Electroencephalography (EEG) is another commonly used noninvasive technique
to probe the brain; it assesses electrophysiologic activity rather than hemodynamics.
However, transcranial EEG has poor spatial resolution and is very sensitive to artifacts,
which limits its use in the clinic [12]. Thus, there is currently a lack of non-invasive
monitoring tools capable of providing real-time, reliable long-term information about the
cerebral physiology at the bedside. This is specially lacking for applications in the field,
such as during sports and in military fields.
More recently, diffuse optical spectroscopy (DOS) and diffuse correlation spectroscopy
(DCS) have been proposed as noninvasive and continuous bedside monitors capable of
providing neurophysiology information in neurocritical patients. By shining near-infrared
light (650-900 nm) from the scalp, DCS can measure microvascular cerebral blood flow
(CBF), and DOS can measure oxy- and deoxy-hemoglobin concentrations (HbO and HbR,
respectively) [13–21]. In particular, the CBF measurements with DCS have been previ-
ously validated against several different gold standard CBF measures [17, 22–29]. In
addition, the combination of CBF and oxygenation provides an estimate of the cerebral
metabolic rate of oxygen (CMRO2) [30, 31].
The combination of DOS and DCS has been explored to monitor patients in several
clinical and pre-clinical scenarios. For example, diffuse optics have been shown to provide
relevant clinical information for critically-ill neonates [32, 33], including during cardiac
surgeries to treat heart defects [15, 34, 35]. Additionally, many authors have explored the
use of diffuse optics to assess the cerebral hemodynamics during different cerebrovascular
interventions, such as during carotid endarterectomy1 [36–38], during thrombolytic treat-
ments for stroke [39], during head-of-bed manipulations [40–42], during cardiopulmonary
resuscitation [43], and others [44–46]. Diffuse optics have also been used to monitor cere-
bral auto-regulation2, both in healthy and critically ill subjects [18, 25, 47], as well for
assesssing the critical closing pressure of the cerebral circulation3 [26]. Many authors
1Carotid endarterectomy is a surgery that may help to prevent stroke by removing the blockage form
the carotid arteries.
2Cerebral auto-regulation is a neuro-mechanism that aims to maintain adequate and stable cerebral
blood flow.
3Critical closing pressure is the internal pressure at which a blood vessel collapses and closes completely.
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have also validated the optically-derived cerebral hemodynamic parameters for long-term
monitoring of neurocritical patients [24, 47, 48], including for the prediction of hypoxic
[49] and ischemic events [50]. However, the reliability of the technique to provide accurate
real-time information during longitudinal measurement as well as during a few different
clinical interventions remains largely unaddressed.
Relative to other approaches, the key advantage of diffuse optics is its ability to simul-
taneously measure blood flow and tissue blood oxygenation noninvasively (and continu-
ously) at the bedside using portable instrumentation. Compared to TCD, DCS has an
additional advantage: it measures tissue level perfusion, whereas TCD measures cerebral
blood flow velocity in large arteries at the base of the brain. This distinction may be par-
ticularly important when evaluating steno-occlusive disease in which both proximal large
artery flow and leptomeningeal collaterals contribute to perfusion. Optical techniques
also have significant advantages when compared to other traditional imaging modalities,
such as PET and MRI. In addition to providing both CBF and HbO/HbR concentration,
optical monitoring provides significantly better temporal resolution than either MRI or
PET, allowing for the assessment of dynamic cerebral autoregulation [18, 25, 51]. Im-
portantly, the diffuse optical methods are also inexpensive and portable in comparison to
PET and MRI which is a critical advantage given the high burden of vascular disease in
lower- and middle-income countries. Additionally, diffuse optics do not require ionizing
radiation and/or contrast agents, which is generally the case for PET and MRI.
The main goal of this thesis was to show that diffuse optics can aid in real-time
monitoring of neurocritical patients with cerebrovascular diseases. To this end, we divided
the remaining of the thesis in four different chapters corresponding to different studies.
In Chapter 2, we review the fundamental aspects of diffuse optics, and highlight the
main theoretical and experimental considerations required for conducting an experiment
with diffuse optics. In Chapter 3, we report on the translation of a hybrid diffuse optical
system to a neuro-intensive care unit of a public hospital in Brazil for real-time, long-term
monitoring of neuro-critical patients. Then, in Chapter 4, we describe the application of
diffuse optics for monitoring acute ischemic stroke patients undergoing an endovascular
treatment. In Chapter 5, we analyze the advantages of implementing an improved data
analysis algorithm that attempts to separate the extra-cerebral and cerebral contributions
from the optical signal. Finally, in Chapter 6, we summarize the main conclusions of this
thesis, as well as suggest potential directions for future studies in this field.
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Chapter 2
Principles of Diffuse Optics
In a typical diffuse optical experiment, we shine near-infrared light from the scalp and
collect the diffusively reflected photons a distance between 2.5 and 4 cm from the source
(Figure 2.1). Due to diffusive nature of light propagation in human tissues, the measured
photons will carry information about the surface of the cerebral tissues. More specifically,
we can recover information about the microvascular cerebral blood flow (CBF) and cere-
bral oxygenation. In this Chapter, we will provide the fundamental concepts of diffuse
optical methods. More specifically, Section 2.1 will provide the theoretical aspects of both
diffuse optical spectroscopy (DOS) and diffuse correlation spectroscopy (DOS), and Sec-
tion 2.2 will highlight the main experimental considerations for applications in humans,
primarily for cerebral monitoring.
Figure 2.1: Pictorial representation of the average path of the detected photons for a
typical diffuse optical experiments with source-detector separations between 2.5 and 4
cm, which is a generally a good compromise between a good SNR and brain sensitivity.
19
2.1 Theoretical aspects of diffuse optics
2.1.1 Diffuse Optical Spectroscopy
The problem of light transport inside turbid media can be modeled by the Radiative
Transport Equation (RTE), or Boltzmann transport (ignoring polarization effects). The
RTE is an approximation of Maxwell’s equation, and can be written as [13, 52, 53]:
1
v
∂L(~r, Ωˆ, t)
∂t
+Ωˆ.∇L(~r, Ωˆ, t) = Q(~r, Ωˆ, t)+µs
∮
L(~r, Ωˆ, t)f(Ωˆ, Ωˆ′)dΩˆ′−µtL(~r, Ωˆ, t), (2.1)
where L(~r, Ωˆ, t) is the radiance, defined as the average power at position ~r and instant t
across the area oriented in the direction of the unit vector Ωˆ; v is the speed of light inside
the medium; µt = µa+µs is the transport coefficient, whereas µa and µs are the absorption
and scattering coefficients, respectively; f(Ωˆ, Ωˆ′) represents the scattering phase function,
i.e., the probability of a photon coming from the direction Ωˆ is scattered into Ωˆ′, and;
Q(~r, Ωˆ, t) is a source term. The RTE (Equation 2.1) is an energy conservation equation,
i.e., any change in radiance at a specific region, ~r, propagating in the direction Ωˆ at time
t (left side of the equation) is equal to the input power from any sources (first term in
the right side of Equation 2.1), plus the power scattered from all other directions into Ωˆ
(second term of the right side of Equation 2.1) minus the power that is scattered to other
directions and/or absorbed (third term of Equation 2.1).
To arrive at the RTE, a few assumptions are necessary: 1) intensity is transferred
element-wise (based on the principle of energy conservation), and thus, on average, there
is no interference of electric fields between different multiple scattering paths; 2) back-
scattering is insignificant when compared to the scattering to other directions; 3) the
scattering particles are non-interacting; 4) the incident source is perfectly monochromatic,
and; 5) the scattering particles are sufficiently distant from each other (much greater than
one wavelength), so that we can use a far-field approximation [54].
Analytic solutions to the RTE are only available for very simple and highly symmetric
media. However, for highly scattering tissues, it is possible to derive a diffusion equation
with a simple approximation of the RTE (Equation 2.1). By expanding L(~r, Ωˆ, t) in terms
of the spherical harmonics, Y m` , up to terms with ` = 1 (the P1 approximation), we can
write the radiance as [20, 21, 53, 55]:
L(~r, Ωˆ, t) =
1
4pi
φ(~r, t) +
3
4pi
~J(~r, t) · Ωˆ, (2.2)
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where φ(~r, t) is the fluence rate and is defined as the integral of the radiance over all
angles, and represents the number of photons per unit area per unit time, and ~J(~r, t) · Ωˆ
is the photon flux leaving position ~r in the direction Ωˆ at instant t. By substituting
Equation 2.2 in Equation 2.1, we obtain the diffusion equation for the photon fluence [13,
20, 21, 53, 55]:
~∇ · [D(~r, t)∇φ(~r, t)]− vµaφ(~r, t)− ∂φ(~r, t)
∂t
= −vS(~r, t), (2.3)
where S(~r, t) is an isotropic source term, D(~r) is the diffusion coefficient, defined as
D(~r) = v/(3µ′t(~r)) = v/(3(µa(~r)+µ
′
s(~r))), and µ′s is the reduced scattering coefficient. The
reduced scattering coefficient, or random-walk coefficient, can be written as µ′s = µs(1−g),
where g = 〈cos θ〉 is the anisotropy factor.
The validity of the diffusion equation rests on a few important assumptions [13, 20,
53]:
1. The RTE is valid. This is often the case for unpolarized light propagating in media
with `a = 1/µa and `s = 1/µs much greater than the light wavelength, λ;
2. Light radiance is nearly isotropic. This is a requirement from the P1 approximation
(i.e., φ | ~J |), and is usually valid for highly scattering media (µ′s  µa);
3. Rotational symmetry. The diffusion equation assumes that µa, µs and f are inde-
pendent of the propagation direction of the photons;
4. Slow temporal variation in photon flux. As discussed in [20], this is valid for f 
32GHz, where f is the modulation frequency of the input source;
5. Light sources are isotropic.
For biological tissues, all of these assumptions are generally valid in the near-infrared
region (∼ 650− 900 nm), where light is predominantly scattered (i.e., µ′s  µa) [20, 53].
Most commonly, biological tissue is approximated by a semi-infinite medium (Fig-
ure 2.2), which is composed of a non-scattering (e.g., air) and a diffusive medium (e.g.,
a human head). Since there will be a refractive index mismatch between each medium,
there will be Fresnel reflections at the boundary. The exact formalism to deal with the
Fresnel reflection in a semi-infinite medium is the partial flux boundary condition [56].
However, the partial flux boundary condition involves integral terms that are too difficult
for practical purposes. Patterson et al. and Farrel et al. have employed a more palatable
boundary condition in which the fluence is set to zero at an extrapolated boundary located
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Figure 2.2: Representation of a semi-infinite medium in the extrapolated boundary condi-
tion. The semi-infinite medium is composed of a non-scattering (top layer) and a diffusive
medium (bottom layer), with refractive indexes nout and nin, respectively. Here, we rep-
resent the extrapolated boundary condition in which the fluence (Φ) is set to zero at a
distance zb above the diffusive medium. We also represent the standard measurement
procedure, where we add a source and a detector at medium boundary, separated by
a distance ρ. In yellow, we represent the method of images used to solve the diffusion
equation. This Figure was extracted from [21].
at a distance zb, outside the diffusive medium (Figure 2.2) [57, 58]. The extrapolated zero
distance, zb, can written as [56]:
zb =
1 +Reff
1−Reff
2
3
z0. (2.4)
Here, z0 = l′t = 1/µ′t is the reduced mean transport length, where µ′t = µa + µ′s is
the reduced mean transport coefficient. The effective Fresnel reflectivity (Reff ) can be
approximated as:
Reff ≈ −1.44
(
nin
nout
)−2
+ 0.701
(
nin
nout
)−1
+ 0.064
(
nin
nout
)
+ 0.668, (2.5)
where nin and nout are the index of refraction of the diffusive and non-scattering media,
respectively (Figure 2.2). Note that the extrapolated zero boundary condition is an
approximation of the exact partial flux boundary condition.
To solve Equation 2.3 for a semi-infinite medium with the extrapolated zero boundary
condition, we can use the method of images by adding one imaginary (negative) source in
the non-scattering medium, as seen in Figure 2.2. Here, the real source was placed inside
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the medium at a depth z = z0, which is the average distance in which the direction of
the photon propagation is randomized (or the mean random walk distance). By assuming
the source is positioned at z0, we can consider the source to be approximately isotropic.
This approximation is valid (less than 5% error) for large source-detector separations
(ρ 10/(µa + µ′s)) [53, 56, 58].
In practical applications of diffuse optics, there are three main types of sources com-
monly employed: continuous-wave (CW), intensity-modulated (or frequency-domain, FD)
and time-pulsed (or time-domain, TD). Each type of source requires a different solution
to Equation 2.3, using the appropriate domain. When working with time-pulsed sources,
we can solve Equation 2.3 in the time-domain with the extrapolated boundary condition
by assuming a unitary input source term S(~r, t) = δ(t − t0)δ(~r − ~r0) (i.e., using Green’s
method). In this regime, we can show that the fluence measured at the medium boundary
a distance ρ from the source is [13, 20, 59]:
TD Solution: φG(~r, t) =
v exp [−vµa(t− t0)]
(4piD(t− t0))3/2
(
exp
[
− r
2
1
4D(t− t0)
]
−
exp
[
− r
2
2
4D(t− t0)
])
,
(2.6)
where r1 =
√
(z − z0)2 + ρ2, r2 =
√
(z + 2zb + z0)2 + ρ2, v is the speed of light in the
medium, t0 is the injection time of photons, and D is the diffusion coefficient (from
Equation 2.3).
If instead of a time-pulsed laser, we have an intensity modulated source at an angular
frequency ω = 2pif , we can set S(~r, t) = δ(ω)δ(~r − ~r0) and take a Fourier transform of
Equation 2.3 to arrive at the frequency-domain (FD) diffusion equation:
(∇2 −K20)φG(~r, ω) = δ(~r − ~r0)δ(ω). (2.7)
The general solution of Equation 2.7 is a spherical wave with wave vector K20 = (vµa +
iω)/D. By solving Equation 2.7 for a semi-infinite medium with the extrapolated bound-
ary condition, we can show that for an intensity-modulated source the fluence measured
on the medium boundary a distance ρ from the point of illumination is:
FD Solution: φG(~r, ω) =
v
4piD
(
e−K0r1
r1
− e
−K0r2
r2
)
, (2.8)
where r1 and r2 were previously defined for the TD solution, and represent the distances
of the real and imaginary sources with respect to the point of measurement, respectively
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(Figure 2.2). By taking the w → 0 limit in Equation 2.8, we arrive at the semi-infinite
solution for a continuous-wave (CW) source:
CW Solution: φG(~r) =
v
4piD
(
e−KCW r1
r1
− e
−KCW r2
r2
)
, (2.9)
where K2CW = K20(ω → 0) = µa/D.
2.1.2 Diffuse Correlation Spectroscopy
In the previous section, we were only interested in the slow changes in the optical proper-
ties of the medium and we ignored the movement of the scattering particles. To account
for the mean squared displacement of the scattering particles (〈∆r2〉), we can derive a
Correlation Transport Equation (CTE) by introducing small changes to the RTE (Equa-
tion 2.1). First, recall that that the radiance, L(~r, Ω̂, t), is the average intensity and can
be written as:
L(~r, Ω̂, t) = 〈I(~r, Ω̂, t)〉 ∝ 〈 ~E(~r, Ω̂, t) ~E∗(~r, Ω̂, t)〉, (2.10)
where 〈〉 is an ensemble average, and I(~r, Ω̂, t) and ~E(~r, Ω̂, t) are respectively the intensity
and total electric field at point ~r and time t propagating in the Ω̂ direction. Interestingly,
the time-dependent electric-field correlation function (G1(~r, Ω̂, t, τ)) is defined in a similar
form:
G1(~r, Ω̂, t, τ) = 〈 ~E(~r, Ω̂, t) ~E∗(~r, Ω̂, t+ τ)〉. (2.11)
Since the time-dependent electric field correlation function is proportional to the ra-
diance at zero delay times (i.e., G1(~r, t, Ω̂, τ = 0) ∝ L(~r, Ω̂, t)), it is reasonable to expect
that the CTE is identical to the RTE at zero delay times (τ = 0). In previous studies,
Ackerson et al. and Dougherty et al. have shown that the CTE can be written as [54,
60]:
1
v
∂G1(~r, Ω̂, t, τ)
∂t
+ Ω̂.∇G1(~r, Ω̂, t, τ) =Q(~r, Ω̂, t)
+µs
∮
G1(~r, Ω̂, t, τ)g
s
1(Ω̂, Ω̂
′, τ)f(Ω̂, Ω̂′)dΩ̂′
−µtG1(~r, Ω̂, t, τ),
(2.12)
where µt = µa+µs is the transport coefficient and f(Ω̂, Ω̂′) is the scattering phase function
from Equation 2.1. The single-scattering auto-correlation function, gs1(Ω̂, Ω̂′, τ), can be
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written as [21, 54, 55, 60]:
gs1(τ) = exp
[
−1
6
q2〈∆r2(τ)〉
]
, (2.13)
where 〈∆r2(τ)〉 is the mean square displacement of the scattering particles; ~q = ~kout−~kin is
the momentum transfer, with amplitude q = 2k0 sin(θ/2); ~kin and ~kout are the incident and
scattered wave vectors, where kin = kout = k0 = 2pin/λ. When comparing Equations 2.1
and 2.12, it is clear that in the τ → 0 limit, the CTE reduces to the RTE, as expected.
In the derivation of the CTE, apart from the necessary assumptions from the RTE
(refer to Section 2.1.1), it is also assumed that the scattering particles are sufficiently
separated, such that each scattering event can be considered independent. Additionally,
in the CTE (Equation 2.12) it is also implicitly assumed that the speed of the scattering
particles is much slower than the speed of light, and thus the correlation can be considered
as instantaneous. Note that the CTE can be derived from a perturbative solution to
Maxwell’s equation [54].
The main difference between the CTE and the RTE comes from the second term on
the right side of Equation 2.12, which describes the amount of radiance, or correlation,
scattered into Ω̂ from all other directions. In the RTE, energy is conserved and each
scattering event does not alter the radiance, but correlation is not conserved in the CTE.
After each scattering event, the amount of correlation transferred depends upon the single
scattering correlation function, gs1(τ), which decreases with increasing delay times. Thus,
correlation is transferred less and less into the Ω̂ direction as τ increases.
Since the RTE and the CTE are formally similar, it is also possible to arrive at a
diffusion equation for the field auto-correlation function using the P1 approximation (refer
to Appendix A.2 of [55]). Focusing on the continuous wave (CW) case, we can arrive at:
v
(
µa +
1
3
µ′sκ
2
0〈∆r2(τ)〉
)
G1(~r, τ)−∇ · [D(~r)∇ (G1(~r, τ))] = vS(~r), (2.14)
where v is the speed of light in the medium; µa and µ′s are the absorption and reduced
scattering coefficients; κ0 = 2pi/λ is the incident wave vector; D(~r) = v/(3µ′t) is the photon
diffusion coefficient, and; 〈∆r2(τ)〉 is the mean square displacement of the scattering
particles. In the derivation of Equation 2.14, it is assumed that the scattering phase
function (f(Ω̂, Ω̂′)) and the single scattering auto-correlation function (g1(Ω̂, Ω̂′, τ)) only
depends on the scattering angle (Ω̂ · Ω̂′) and that k20〈∆r2(τ)〉  1.
For homogeneous media, i.e., media where µa, µ′s and 〈∆r2(τ)〉 are position indepen-
25
dent, we can recast Equation 2.14 as a Helmholtz equation for the field auto-correlation
function: (∇2 −K2(τ))G1(~r, τ) = −vS
D
δ3(~r − ~r0), (2.15)
where K2(τ) = v
(
µa +
1
3
µ′sk
2
0〈∆r2(τ)〉
)
/D. In Equation 2.15 we additionally assumed a
point-like source term, located at ~r0. Since Equation 2.15 is formally identical to Equa-
tion 2.7, we can solve the correlation diffusion equation for a semi-infinite medium using
the same methods from Section 2.1.1, but with a different wave-vector (K0(ω)→ K(τ)):
DCS Solution: G1(~r, τ) =
v
4piD
[
e−K(τ)r1
r1
− e
−K(τ)r2
r2
]
. (2.16)
Note that G1(~r, τ) depends on µa and µ′s, in addition to 〈∆r2(τ)〉.
2.2 Experimental methods of diffuse optics
In this section, we highlight the main experimental considerations necessary to conduct
a diffuse optical measurement. We first briefly overview a few important considerations
required for applications in human tissues, which is the main goal of this thesis, and then
describe the instrumentation as well as the fitting steps for each type of source. In Sec-
tion 2.2.1, we describe the experimental methods for the three types of sources employed
in DOS measurements, and in Section 2.2.2, we describe the experimental methods for
DOS experiments.
2.2.1 Diffuse Optical Spectroscopy
Although theoretically similar, there are distinct experimental and theoretical consider-
ations for each type of source commonly employed for DOS measurements. Depending
on the source type, we will have access to different features of the scattered light: with
CW sources, we can only recover the changes in light intensity; with frequency-modulated
sources (FD), we can recover the amplitude changes and phase shifts, and; with pulsed
sources (TD), we can recover the distribution of time of flights of the diffusively scattered
photons (Figure 2.3). In Section 2.2.1.1, we describe a few important considerations nec-
essary for human applications, and then in Sections 2.2.1.2 - 2.2.1.4, we briefly describe
the most important experimental considerations for each type of source.
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Figure 2.3: Representative signals from the three different DOS techniques. (A) Contin-
uous wave (B) Time-Domain (C) Frequency-Domain. Modified from [21].
2.2.1.1 Considerations for human applications
In the near-infrared range (NIR, 600-900 nm), there is a biological window with low
absorption but high scattering where the diffusive approximation is valid. For human
tissue, the main absorbers in the NIR are the oxy- and deoxy-hemoglobin (HbO and
HbR, respectively) and water (Figure 2.4). Of importance, melanin also absorbs light in
the NIR, but it is possible to ignore its contribution since melanin is restricted to a very
thin upper layer of the tissue. Finally, we can write the absorption coefficient as a linear
mixture of the contribution from each chromophore:
µa(λ) =
∑
εi(λ)ci = εHbO(λ)HbO + εHbR(λ)HbR + µa,H2O(λ)fH2O, (2.17)
where εi(λ) and ci are the extinction coefficient and the concentration of the ith chro-
mophore, respectively, µa,H2O is the water absorption coefficient and fH2O is the water
fraction in tissue. Additionally, for human measurements, we expect a Mie-type scatter-
ing, and thus we can write the reduced scattering coefficient as [61, 62]:
µ′s = A
(
λ
800
)−b
, (2.18)
where A and b are related to the size, index of refraction, and the concentration of scat-
terers in tissue, and λ is given in nm.
By measuring the oxy- and deoxy-hemoglobin concentrations, it is useful to compute
the total hemoglobin concentration (HbT = HbO + HbR), which is proportional to the
tissue blood volume. Additionally, we can also estimate the tissue oxygen saturation
(StO2 = HbO / HbT), as well as the oxygen extraction fraction (OEF). The OEF can be
estimated with [30, 31]:
OEF =
1
γ
SaO2 − StO2
SaO2
, (2.19)
27
Figure 2.4: Extinction coefficients of the main components of human tissue. In general,
the main absorbing particles in human tissue are the oxy- (HbO, red line) and deoxy-
hemoglobin (HbR, blue line), as well as water (H2O, black line).
where SaO2 is the arterial blood oxygen saturation, and γ is the percentage of blood
volume contained in the venous compartment of the vascular system, usually assumed to
be 0.75 [63].
In general, to accurately recover the concentration of N chromophores, we need mea-
surements with at leastM ≥ N different wavelengths to solve a well-posedM×N system
of equations (from Equation 2.17). For DOS applications in humans, a minimum of two
wavelengths is necessary as we are only interested in the HbO and HbR concentrations,
since we can assume a constant water fraction in tissue (fH2O ≈ 75%). Corlu et al. de-
veloped a formalism to define the optimal wavelengths to maximize the accuracy in the
recovery of the concentration of the different chromophores [61, 64]. For example, to max-
imize the accuracy of the recovery of HbO and HbR, while assuming constant A and b,
they proposed that for a set of three wavelengths, the optimum choices are: (650±2) nm,
(716± 4) nm, and (902± 16) nm. It is worth noting that by employing more wavelengths
we can increase the accuracy in the recovery of the chromophore concentrations, but this
will also increase the cost and complexity of the instrument.
2.2.1.2 Continuous-Wave Diffuse Optical Spectroscopy
The simplest approach for DOS measurements is the use of CW sources. In this ap-
proach, we only have access to changes in light intensity (Figure 2.3-A) at each wave-
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length. Theoretically, CW-DOS (commonly referred in the literature as near-infrared
spectroscopy, NIRS) is only sensitive to an effective transport coefficient, defined as
µeff = K0(ω → 0) =
√
3µa (µa + µ′s), and it is unable to uniquely separate the effects of
absorption and scattering in homogeneous tissues [64, 65]. To overcome this issue, most
studies use a Modified Beer-Lambert Law (MBLL) formalism that relates changes in the
optical density (OD) to changes in absorption [66, 67]. The OD is defined as:
OD(t, λ) ≡ − log I(t, λ)
I0(t, λ)
= µa(t, λ)L, (2.20)
where I and I0 are respectively the detected and incident light intensities, and L is the
linear photon pathlength inside the medium.
To arrive at the MBLL, we assume that after some time there will be absorption
changes (µa ⇒ µa + ∆µa) but the scattering will remain constant (∆µ′s = 0). With
this assumption, we can write the changes in optical density (∆OD) due to changes in
absorption as:
∆OD(t, λ) = OD(t, µa + ∆µa, µ
′
s)−OD(t0, µa, µ′s) =
hhhhhhhOD(t, µa, µ
′
s) +
∂OD(t, µa, µ
′
s)
∂µa
∆µa +
*0O(2)−hhhhhhhhOD(t0, µa, µ′s),
(2.21)
where we expanded OD(t, µa + ∆µa, µ′s) in terms of the variation in the absorption coeffi-
cient (∆µa). By neglecting the higher order terms and using Equation 2.20, we arrive at
the MBLL [66]:
∆OD(t, λ) = − ln
(
I(t, λ)
I(t0, λ)
)
=
∂OD(t, µa, µ
′
s)
∂µa︸ ︷︷ ︸
lDPF
∆µa(t, λ), (2.22)
where t0 is a baseline period and lDPF is the photon’s differential pathlength, and is
roughly a correction to the non-linearity of the photon paths due to scattering. With
Equation 2.22, it is possible to measure absorption changes (∆µa) without directly mea-
suring µa and µ′s. By measuring changes in the absorption coefficient, we can also measure
changes in the chromophore concentrations:
− 1
lDPF
∆OD(t, λ) = ∆µa(t, λ) =
∑
εi(t, λ)∆ci =
εHbO(t, λ)∆[HbO] + εHbR(t, λ)∆[HbR],
(2.23)
where we considered a constant water fraction.
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Currently, there are several commercially available CW-DOS instruments [67], ranging
from few thousand dollars to several hundred thousand dollars. A typical NIRS instrument
is relatively simple, as we only need to measure changes in light-intensity. Most systems
employ either laser-diodes or LEDs as sources. In general, laser-diodes provide higher
power, have a narrower spectrum (<1 nm) and are easier to collimate into fiber-optics.
However, laser-diodes are generally more expensive and often come in bulky packaging due
to cooling and power requirements. On the other hand, although LEDs have a broader
emission spectrum (∼ 30 nm), they can be applied directly on the body surface without
need for optical fibers, and they are relatively inexpensive and do not require sophisticated
cooling and power supplies.
To detect the changes in light intensity, CW-DOS instruments usually employ ei-
ther photodiodes or avalanche photodiodes (APD). Photodiodes have a large dynamic
range (<100 dB) and are easy to use. However, photodiodes usually require low-noise
pre-amplifiers, as they have lower internal gains. On the other hand, APDs have higher
internal gains and are more sensitive to light-intensity changes, while still having a reason-
able dynamic range (<60 dB). However, since the operating voltage of an APD is in the
order of tens to hundreds of volts, it is hard to safely place the APDs directly on the body
surface, and thus they usually require coupling to fiber-optics. Due to the dependency
of the internal gain on temperature and bias voltage, APDs also require stabilized power
supplies and often need cooling.
Since CW-DOS instrumentation is relatively simple and inexpensive, it is possible to
combine several sources and detectors in a single, relatively small instrument without
drastically increasing the cost. For example, with multiple source and detector pairs it
is possible to cover a wide area on the head, even allowing whole-head measurements
[68–73]. Additionally, with multiple source-detector pairs it is also possible to reconstruct
images of brain activation, which have been validated against functional MRI [74]. Due
to the low-cost of CW-DOS, some authors have even suggested wireless instrumentation,
which allow measurements in natural environments, such as in parks and during physical
activity [75–78].
The number of CW-DOS (or NIRS) studies exponentially increased over the last
decade, with the majority of studies focusing in functional studies of the brain [19, 67, 79,
80]. Regarding clinical applications, CW-DOS is currently employed as a complementary
physiological monitor in several clinical scenarios (e.g., cardiovascular surgeries) [46, 81–
87]. However, since CW-DOS is only capable of measuring changes in oxygenation, it has
been limited as trend monitors, therefore being susceptible to systemic physiological oscil-
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lations and diminishing its usefulness for longitudinal monitoring of neurocritical patients
[88–93]. For more details about CW-DOS, we refer the reader to recent comprehensive
reviews [19, 67, 80, 82].
2.2.1.3 Frequency-domain diffuse optical spectroscopy
By employing frequency-modulated sources and by measuring changes in the amplitude
and phase of the scattered wave, we can measure the absolute optical properties of the
tissue. In a typical FD-DOS experiment, we employ multiple source-detector separations
to recover µa and µ′s at multiple wavelengths [13, 53, 94, 95]. For this, a simplification of
Equation 2.8 for large source-detector separations is often employed [21, 53]. If we assume
that ρ >> lt + 2zb, we obtain:
φG(~r, ~r0, ω) =
v
4piD
e−K0,Reρ
ρ2
[
2K0(zblt + z
2
b )
]
︸ ︷︷ ︸
A(ρ)
e
θ(ρ)︷ ︸︸ ︷
−iK0,Imρ, (2.24)
where K0,Re and K0,Im are respectively the real and imaginary parts of the wave vector
K0. From Equation 2.24, we can see that the phase (θ(ρ)) and the logarithm of the
amplitude times ρ2 (ln (A(ρ)ρ2)) are linearly dependent on the source-detector separation
(ρ):
ln
(
ρ2A(ρ)
)
= −K0,Reρ+ lnA0 (2.25a)
θ(ρ) = −iK0,Imρ+ θ0. (2.25b)
Thus, with a simple linear fitting procedure we can recover K0,Re and K0,Im, from which
we can compute the absorption and scattering coefficients with:
K20 =
vµa + iω
D
⇒
µa =
ω(−K20,Re+k2Im)
2vK0,ReK0,Im
µ′s = −v 2K0,ReK0,Im3ω
. (2.26)
Note that instead of using the approximation for large source-detector, it is also possible
to recover the optical coefficients with a non-linear fit using Equation 2.8.
Although most FD-DOS instruments use a single modulation frequency and multiple
source-detector separations to recover the optical properties, the requirement for multiple
sources and detectors increases the complexity of the measurement as well as the cost of
the instrument. The use of several source-detector separations requires multiple optical
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fibers to be attached to the head, and thus a careful calibration of the coupling coefficient
for each separation is necessary, which may introduce additional errors in the retrieval of
the optical properties. It is possible to estimate the coupling coefficient for each source-
detector separation by measuring a phantom with known optical properties. However,
there may be differences in contact between the calibration measurement on the phantom
and the actual experiment. Furthermore, since each source-detector separation will probe
slightly different regions, the presence of heterogeneities may also reduce the reliability of
the optical properties retrieval.
To use a single source-detector separation to retrieve absolute values of µa and µ′s, we
can vary the modulation frequency, typically between 100 and 700 MHz. By using a single
source-detector separation, we will reduce the system cost, as it will require a single PMT
and a single laser-diode. Until recently, multi-frequency instruments were restricted to
bench-top as they usually required expensive bulky network analyzers. However, Torjesen
et al. recently proposed an inexpensive system that fully integrates digital signal synthesis
and detection to rapidly acquire the amplitude and phase shifts for multiple wavelengths,
with frequency sweeps between 50 and 400 MHz, at a repetition rates up to 97 Hz [96].
The biggest disadvantage of multi-frequency measurements is the need for non-linear
methods to retrieve the optical properties. However, since we are measuring with a single
source-detector separation, we will be less sensitive to heterogeneities as the probed region
across each modulation frequency will be more confined than the region probe by multiple
source-detector separations.
The biggest advantage of FD-DOS over CW-DOS is the ability to measure phase
shifts. In addition to allowing the absolute estimations of the optical coefficients, phase
measurements are also more biased toward longer-photon paths [97]; photons with longer
paths are likely to undergo more scattering events and thus have larger phase shifts. This
is especially relevant for cerebral measurements, where we are mostly interested in changes
in the cerebral tissues, which are approximately 1.2cm below the scalp. As an example,
a recent study showed that it is possible to improve the depth accuracy of diffuse optical
tomography (DOT) by using the phase information from FD instruments [97].
Most FD-DOS instruments use laser diodes modulated with an oscillating driving
current. Due to their relatively fast time responses, it is possible to modulate laser-
diodes at frequencies up to the gigahertz range [53]. The most common optical detectors
employed in FD-DOS instruments are photomultiplier tubes (PMT) and APDs, but some
instruments also employ CCD cameras in conjunction with a gated image intensifier [53,
96, 98–103]. For a detailed review about the instrumentation of FD-DOS, we refer the
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reader to [53].
2.2.1.4 Time-domain diffuse optical spectroscopy
In TD-DOS experiments, we measure the absorption and scattering coefficients of the
tissue by shining a pulsed source to the tissue and by measuring the photon distribution
of time-of-flight (DTOF) a distance ρ away from the source [13, 59, 104]. The DTOF
is a histogram of the number of photons striking the detector as function of the time
difference between the source trigger and the photon detection at time t. Due to light
propagation through the tissue, the light pulse will be delayed, broadened and attenuated
due to absorption and scattering. More specifically, broadening occurs due to the different
photon pathlengths due to scattering, while attenuation occurs due to absorption and
scattering to other directions. By increasing the scattering coefficient, we increase the
delay and broadening of the pulse, and an increase in absorption affects the slope of the
tail of the DTOF.
It is worth noting that there are other factors that introduce delays, broadening and
attenuation of the light pulse, such as the source-detector separation and the delivery and
collection optics. An increase in the source–detector distance yields an increased delay
and broadening of the DTOF and decreases the number of detected photons, similarly to
an increase in scattering. However, differently from CW-DOS and FD-DOS, the depth-
sensitivity of TD-DOS is not directly related to the source-detector separation. Instead,
since TD-DOS measures the arrival time of each photon, it is possible to discriminate
between the early (superficial) and late (deep) arriving photons [105, 106]. Thus, it is
possible to selectively analyze the late arriving photons, which are shown to be more
sensitive to deeper tissues, such as the cortex.
Since the lasers and detectors employed in TD-DOS experiments are generally bulkier
and require dangerous voltages, most studies employ fiber optics to deliver and collect light
from the tissue. However, modal dispersion in the fiber optics will further broaden the light
pulse. Modal dispersion can be greatly reduced by a proper design of the refraction index
profile of the optical fibers. For example, graded-index fibers have negligible temporal
dispersion (<1 ps/m), but have lower core diameter (<200 µm) and numerical aperture
(NA, <0.3). Although graded-index fibers are often employed to deliver light to the tissue,
they are not suitable to collect light from the tissue. The detected intensity in TD-DOS
experiments is usually very small, and thus step-index optical fibers with high NA (<0.6)
and large diameters (up to 3 mm) are usually required. However, step-index fibers have
33
higher temporal dispersion (<100 ps/m), and thus care must be taken with the length of
the detection fibers. We note that the attenuation of both graded-index and step-index
fibers is negligible for TD-DOS experiments, which are generally limited to optical fibers
with less than 10 meters.
Typically, in TD-DOS experiments we measure the DTOF at a single source-detector
separation but with multiple wavelengths. Most studies use either non-linear fitting algo-
rithms [13, 59, 107–109] or semi-empirical methods [110–113] to recover the optical prop-
erties. Regardless of the analysis algorithm employed, to accurately recover the optical
properties of the tissue we need to account for the additional time-delay and broadening
caused by the detector and pulse-width of the source. To that end, we can measure the
instrument response function (IRF) by directly coupling the light-source and the detector
[114]. For example, for non-linear fitting algorithms, we can account for the IRF by con-
volving the theoretical fluence from Equation 2.6 with the measured IRF. Note that the
use of longer optical fibers and poor selection of the temporal resolution of the detector
and source may lead to an unacceptable width of the IRF; IRFs with a full width at half
maximum (FWHM) larger than 1 ns compromise the accuracy of TD-DOS measurements
[115].
To reduce the FWHM of the IRF, care must be taken when designing TD-DOS in-
struments to choose laser sources and detectors with good temporal resolutions. Most
TD-DOS instruments reported in the literature use laser diodes, which have high repe-
tition rates (up to 100 MHz), relatively short pulses (100-200ps) and reasonable output
power (1mW-1W). However, it is important to mention that increasing the power of laser-
diodes generally will also broaden the pulse, which may be detrimental for applications
with poor SNR. Besides good temporal resolution, the biggest advantage of laser-diodes
is that they are relatively compact and they are currently commercially available at mul-
tiple vendors. More recently, some authors employed supercontinuum lasers for TD-DOS
measurements, which have pulses shorter than <10 ps, and repetition rates of tens of
megahertz. The biggest advantage of supercontinuum lasers is their high spectral bright-
ness (∼ 1mW/nm) and the possibility to automatically select the wavelength and power,
with the proper optoelectronic accessories [23, 50, 116, 117]. Note that supercontinuum
lasers are also relatively compact and suitable for portable systems.
To detect the weak light signals from TD-DOS, we need detectors with good temporal
resolution (in the range of 1-250 ps), and sufficient sensitivity. Among the available
options, PMTs and hybrid-PMTs [118] are the most commonly employed due to their fast
response and large active area. Single-photon avalanche diodes (SPAD) have potentially
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faster temporal responses and higher sensitivity than PMTs, but SPAD generally have
worse SNR due to their smaller active area when compared to PMTs. Finally, to detect
the voltage pulses from the detector, most studies use the time-correlated single-photon
counting (TCSPC) technique. Briefly, in TCSPC experiments each voltage pulse from the
detector is time-stamped with the arrival time of the photon based on a synchronization
signal. This time-stamp can then be used to build up the DTOF after multiple cycles.
For an in-depth review of the TCSPC technique (including applications to TD-DOS), we
refer the reader to [118].
The biggest disadvantage when working with TCSPC is that we are unable to process
more than ∼ 106 photon counts per second. This limits our ability to measure the
later arriving photons, as the majority of the photons will be on the earlier portions of
the DTOF. Additionally, to measure multiple wavelengths, we need to either compute the
DTOF in parallel using different timing electronics (increasing the cost of the instrument)
or we need to share the maximum count-rate between each wavelength, further decreasing
our sensitivity to the later photons. To overcome the issue of maximum photon counts,
some authors have suggested the use of time-gating techniques to selectively measure the
late arriving photons [59, 104, 110, 119–122]. Time-to-digital converters that allow higher
maximum counting rates were also proposed [59, 104, 123, 124].
For a more detailed review about TD-DOS and its instrumentation, as well as for
future prospects of the technique, we refer the reader to [59, 104].
2.2.2 Diffuse Correlation Spectroscopy
2.2.2.1 Considerations for human applications
In Section 2.1.2, we developed a formalism to measure the mean square displacement of
the moving scattering particles from the auto-correlation function of the electric field.
However, there are two main issues with that formalism: 1) experimentally, we only have
access to the intensity auto-correlation function (g2(τ) = 〈I(t)I(t + τ)〉/〈I(t)〉2), and; 2)
there may be static (or slowly moving) scattering particles mixed with the fast moving
particles.
Since experimentally we only have access to the intensity auto-correlation function
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g2(τ), we must use Siegert’s Relation [125]:
g2(τ) = 1 + β|g1(τ)|2, (2.27)
where g2(τ) = G2(τ)/〈I(0)〉2 and g1(τ) = G1(τ)/〈I(0)〉 are the normalized intensity and
field auto-correlation functions, respectively, and; β is an experimental parameter that
depends on the source and the collection optics. For example, when using single-mode
fibers and non-polarized light, we expect β = 0.5. In general, we expect β ≈ 1/N , where
N is the number of modes allowed to propagate in the detection fiber, which is related to
the fiber core diameter [20, 21, 125].
Before applying Equation 2.15 to biological tissues, one extra modification must be
made to account for the static scatterers, as they do not contribute to the loss of cor-
relation. To this end, we need to take into account the probability that a photon will
be scattered by a moving particle. In human measurements, the main moving scatterer
measured by DCS are the red blood cells (RBC), and we can define the probability of
scattering by a RBC, α, as:
α = fblood
µ′s,blood
µ′s,avg
= fblood
µ′s,blood
fbloodµ′s,blood + (1− fblood)µ′s,tissue
, (2.28)
where fblood is the volume fraction of blood, µ′s,blood is the scattering coefficient of blood and
µ′s,avg = fbloodµ
′
s,blood+(1−fblood)µ′s,tissue is the volume fraction weighted average scattering
coefficient of tissue and blood. Note that with DOS we are only directly sensitive to µ′s,avg.
Finally, to account for the static scatterers, we can change the wave vector (K(τ)) from
Equation 2.15, so that:
K2(τ) = v
(
µa +
1
3
µ′sk
2
0α〈∆r2(τ)〉
)
/D. (2.29)
The mean square displacement of the RBCs is generally given as:
〈∆r2(τ)〉 = 6DBτ + v2RBCτ 2, (2.30)
where τ is the delay time, DB is a diffusion coefficient, and vRBC is the speed of the RBCs
[13, 126]. Experimentally, it was found that the shear-induced diffusive motion of the
RBCs dominate the correlation decay [126, 127]. Thus, we can ignore the vRBC term,
and we can define a blood flow index as: BFI = αDB. Using Monte-Carlo simulations,
Boas et al. showed that the BFI measured with DCS is indeed a measure of blood flow,
as expected from the previous validation studies. More specifically, they showed that the
36
BFI measured by DCS is directly proportional to the absolute tissue blood flow (BFabs),
and their relation can be written as:
BFI =
8αshear
3
µ′s,blood
µ′s,avg
1
R
BFabs, (2.31)
where αshear is the shear rate, and R is the average vessel radius in the probed region. Of
importance, both the shear rate and the scattering coefficient of blood (αshear and µ′s,blood,
respectively) depend on the hematocrit (i.e., the volume ratio of the RBCs in blood).
Thus, to convert BFI to BFabs, a blood sample to measure the hematocrit, or a direct
measure of both αshear and µ′s,blood may be necessary. Additionally, it is worth noting that
to compute BFI we need knowledge of the average absorption and scattering coefficients of
the tissue (µa,avg and µ′s,avg), which is possible with DOS. Thus, concurrent measurements
of DOS and DCS are necessary to improve the reliability of the DCS measure of blood
flow.
2.2.2.2 Instrumentation considerations
The signal-to-noise ratio (SNR) of a DCS measurement can be estimated as [20, 128, 129]:
SNR(τ) =
g2(τ)− 1
σg2−1
≈ 〈Id〉β
√
tavg
√
T exp (−2Γτ)√
1 + β exp (−Γτ) , (2.32)
where 〈Id〉 is the average intensity measured at the detector, T is the correlator delay-time
bin width, tavg is average time for the computation of the auto-correlation curves and Γ
is the decay rate of the reduced normalized intensity auto-correlation function (g2 − 1).
For a SI medium, we can approximate Γ as:
Γ(τ) ≈√3µaµ′s(2pin0λ
)2
× µ
′
sDB
µa
√(
1
µ′s
)2
+ ρ2. (2.33)
From Equation 2.32, we can see that the SNR of a DCS measurement is primarily affected
by the detected intensity (〈Id〉), the β factor from Sierget’s relation and by the averaging
time of the correlator (tavg).
Thus, one possible method to increase the SNR of a DCS measurement is to increase
〈Id〉, which can be accomplished by either increasing the source power or the detection
efficiency. However, to avoid damaging the tissue, we must adhere to the source power
limits imposed by the regulatory agencies, such as the American National Standards
Institute (ANSI) in the US and the National Sanitary Surveillance Agency (ANVISA) in
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Brazil. For example, for a laser emitting light at λ = 785nm the maximum permissible
power for continuous illumination is 28.4 mW. Note, however, that the lasers commonly
used in DCS experiments are capable outputting up to 100 mW. To use the higher power
outputted by the lasers, but without damaging the tissue and staying within the regulatory
limits, we can illuminate the tissue intermittently. For example, we can increase the
power to 79 mW by illuminating the tissue during 2.5s, interleaved with 4.5s periods
of no illumination [20]. Alternatively, we can also increase the power by increasing the
illumination area. To this end, we can use optical diffusers attached to the tip of optical
fibers to homogeneously deliver light over a wider area. For example, by using a diffuser
with a diameter of 5.5mm, we can continuously illuminate the tissue at 50 mW maximum
[130].
Besides increasing the source power, we can also increase the detected intensity and
the SNR by improving the detection aspects of our measurements. More specifically,
we can improve the SNR by: 1) increasing the number of detection channels used to
compute the averaged auto-correlation curves; 2) using efficient detectors, and/or; 3)
using few-mode fibers. By bundling multiple detection channels at approximately the
same position, we can average multiple auto-correlation curves, which in turn increases
the SNR by approximately
√
N , where N is the number of detection channels. Although
increasing the number of detection channels is the most widely used solution for increasing
the SNR of a DCS measurement, we are usually limited to a few detectors; each additional
detection channel considerably increases the cost and the complexity of a DCS system.
Another option to increase the SNR of DCS is to use high quantum efficiency single-photon
detectors. In practice, the commercially available detectors have a quantum efficiency of
∼ 50% for 785nm light.
We can also increase the detected intensity by using few-mode fibers; the detected
intensity is linearly proportional to the number of modes allowed to propagate in the
optical fiber. However, since β is inversely proportional to the number of modes allowed
to propagate in the fiber, the increase in 〈Id〉 is cancelled by the decrease in β, and the
SNR is approximately unchanged [20, 131]. Additionally, the use of few-mode fibers may
also introduces modal noise, which is not taken into account in Equation 2.32. Thus,
most DCS applications employ high-transmission single-mode fibers.
Although in most DCS applications β is equal to 0.5 (single-mode fibers with non-
polarized light), we could theoretically increase β by in introducing light polarizers. How-
ever, by introducing light polarizers we would also reduce the detected intensity, and thus
we would not necessarily improve the SNR. It is worth mentioning that β is also decreased
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by instrumental factors, such as the dead time and non-linearities of the detector and as-
sociated electronics, as well as the finite sampling time of the correlator. Additionally,
light leakage from the source directly to the detector can also lead to smaller β values.
Finally, the averaging time and the bin-width of the correlator can also affect the
SNR of DCS measurements. The most commonly used method for computing the auto-
correlation curves is the multi-τ scheme, where data are processed simultaneously for
many different sample times, allowing measurements of both small and large values of
τ [21]. In the multi-τ scheme, the delay-times are directly related to the bin-widths.
The bin-widths increase with increasing delay-time, and thus we expect a higher SNR
for the later portions of the auto-correlation curves. In most applications, the averaging
time (tavg) is controlled by the user and can be adjusted according to the need of each
experiment. Note, however, that a minimum tavg may be imposed by the correlator.
For human applications, although using a larger averaging time will lead to higher
SNR, decreases in the sampling time may introduce aliasing due to the oscillating nature
of the blood flow [132, 133]. In human measurements, the DCS measure of blood flow
is sensitive to any hemodynamic events, as well as any hemodynamic oscillations, such
as the heart-beat (∼ 1Hz), the respiration rate (∼ 0.3Hz) and the Mayer waves (∼
0.1Hz) [93, 134–136]. Thus, a compromise between an increase in SNR and the ability to
separate the different hemodynamic changes is necessary. Most studies using DCS were
limited to slower sampling rates (up to 1 Hz) due to the hardware correlator commonly
employed. More recently, Wang et al. proposed a software correlator capable of acquiring
DCS data with sampling rates up to 100 Hz [137]. With their software correlator, it is
possible to change the delay-times, the bin-width and the averaging time as required by
the experiment.
In practice, the design of a DCS instrument requires a few extra considerations, besides
the improvement of the SNR. First, to assure that the correlation loss measured by DCS is
due to the scatterers movement, a long-coherence laser is required; typically, a coherence
length larger than 10 meters is sufficient [20]. Second, besides a high quantum efficiency,
the DCS detectors must have a good timing resolution (faster than 1 ns), a small dead-
time (< 50ns) and small dark counts. In a typical DCS measurement in an adult head, we
expect to measure approximately 20 thousand counts per second, whereas the commonly
employed detectors have less than 500 dark counts per seconds. Thus, we can safely ignore
the effect of the dark counts.
The DCS measurement of blood flow is sensitive to the external pressure of the optical
probe against the tissue. By increasing the probe pressure, we will reduce the blood
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flow in the external tissues, and thus the BFI from DCS is also reduced [138–140]. For
brain measurements, it has recently been shown that although the BFI is reduced due
to the probe pressure, the heart-rate pulsatilty of BFI is unchanged [139]. However,
for measurements on the forearm, the BFI heart-rate pulsatility is also decreased with
increasing probe pressure. Interestingly, it is possible to use these changes in BFI due
to the external probre pressure to separate the extra-cerebral and cerebral physiologies
[140].
Last, the optical-derived CBF has physical units (i.e., cm2/s) rather than the more
usual clinical units (i.e., ml / 100 g of tissue / min). In order to estimate the absolute
CBF measured with DCS in the clinical units a previous calibration of the technique is
required. Some authors have proposed the use of an indocyanine-green (ICG) bolus to
recover absolute CBF in clinical units from a FD-DOS or TD-DOS measurement. This
estimate of CBF with DOS can be used to recover a calibration factor to convert the CBF
index from DCS to the absolute clinical units [23, 117, 141]. In a recent paper, He et
al. showed that the calibration factor from the ICG method is reliable across different
monitoring days and different patients [117]. Additionally, Milej et al. showed that the
ICG method can provide accurate measurements of CBF (when compared to arterial spin
labelling (ASL)-MRI) by using a two-layer model of the head [23].
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Chapter 3
Real-time assessment of cerebral
hemodynamics with diffuse optical
spectroscopies in a neuro intensive care
unit
As previously mentioned in Chapter 1, one of the main goals in the care of patients with
severe neurological conditions, such as stroke or head trauma, is to prevent secondary
damage [2–5]. To this end, close patient monitoring following acute brain lesions is essen-
tial, and it may directly improve mortality and morbidity rates [6–8].
In order to expand the usefulness of diffuse optical methods into the clinic, some
studies have employed frequency- (FD-DOS) and time-domain (TD-DOS) diffuse opti-
cal spectroscopy to measure absolute tissue oxygenation. Either FD-DOS or TD-DOS
can be combined with diffuse correlation spectroscopy (DCS) for measurements of CBF
and metabolism. The combination of DCS and FD/TD-DOS has been explored to mon-
itor patients in several clinical scenarios, e.g., for neonatal monitoring [15, 32–34, 63],
during cerebrovascular interventions [37, 38, 40, 41, 45, 142], as well as for monitoring
of neurocritical patients [47, 49, 50]. However, these studies mostly focused on the ef-
fects of specific events and interventions. Concerning the practical clinical application of
diffuse optical methods, the important question related to the correlation between neu-
rophysiology, as measured by DCS/DOS, and the clinical evolution of patients during
hospitalization remains largely unaddressed 1.
1The results presented in this chapter are partially based on a manuscript we submitted to the journal
Frontiers in Medicine [143]
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3.1 Methods
3.1.1 Subject recruitment
We monitored eight patients for a total of ∼ 30 hours. Four of the eight patients were
diagnosed with ischemic stroke, and four patients with a subarachnoid hemorrhage. The
patients were recruited during their admission to the neuro-ICU of the Clinical Hospital
at the University of Campinas, Brazil. The optical probe was held on the forehead with
a flexible rubber band. Continuous optical measurements were taken for at least 1 hour
per day during the period of the patient hospitalization. Each brain hemisphere was mea-
sured sequentially, for at least thirty minutes on each side. All monitoring sessions were
supervised by a specialized neurologist. The study was carried out in accordance with
the Belmont Report and written informed consent from all subjects (or legally authorized
surrogate) was obtained. The protocol was reviewed and approved by the ethics commit-
tee at the University of Campinas (Protocol number 56602516.2.0000.5404). The ethics
committee approval and the consent form can be found in Appendices B and C.
Due to either excessive patient movement, bad coupling of the optical probe or poor
data quality due to low SNR, we opted to excluded 6 patients from our analysis. Thus,
here we have only focused on two representative case studies. First, we described the case
of a 62-year-old female patient who was admitted to the intensive care unit (neuro-ICU)
following aneurysmal subarachnoid hemorrhage (aSAH). Second, we describe the case of
a 50-years old female who presented with left sided hemiparesis2 and was found to have
an ischemic stroke due to an occlusion on the right MCA.
3.1.2 Experimental protocol
Since this was a pilot observational study, the experimental protocol was designed so that
the optical measurements would not interfere with any clinical practices. Therefore, the
timing of each optical monitoring session was purposely chosen to avoid conflicts with
any planned clinical intervention. The majority of the monitoring sessions happened
in the early afternoon, prior to family visitation hours. No treatment decisions were
made based on the optical measurements. Mean arterial pressure (MAP), arterial blood
oxygen saturation (SaO2), hemoglobin concentration (Hgb) and CBFv from TCD were
retrospectively recovered from the medical records and were taken at most an hour before
2Hemiparesis is a paralysis of one side of the body.
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or after the optical measurements.
3.1.3 Optical instrumentation
For this study, we developed a hybrid diffuse optical instrument employing both a DCS
module and a commercial FD-DOS module (Figure 3.1). The homemade DCS instrument
employs 16 single photon-counting detector arrays (SPCM-AQ4C, Pacer, USA) and one
long-coherence laser emitting at 785 nm (DL785-100-SO, CrystaLaser, USA). The signal
from the detector feeds a hardware correlator (Correlator.com, China) that outputs the
DCS auto-correlation curves. The DCS module was characterized and validated during
my Master’s project [21]. The FD-DOS module (Imagent, ISS Inc., USA) employs 4
photomultiplier tubes as detectors and 32 laser diodes modulated at 110 MHz that provide
8 sources, with four different wavelengths each (690, 705, 750 and 846 nm).
To permit FD-DOS and DCS measurements, we used an Arduino board programmed
inside our control software to automatically switch between each module. The interleaved
measurements of FD-DOS and DCS is necessary in order to avoid damaging the PMTs of
the FD-DOS module due to the high power of the DCS source. The total sampling rate
of our system is ∼ 0.16 Hz. We developed an user-friendly graphical user interface (GUI)
with LabVIEW (National Instruments, USA) to control the operation of both modules
and to display in real-time CBF, StO2, and CMRO2. The GUI was based on current
instruments available at the neuro-ICU, and it was adapted after feedback by clinical
users in order to facilitate its use by hospital staff, such as neurointensivists and nurses.
The GUI displays the real-time CBF, StO2 and CMRO2 values, in both a 5 minutes and
in a 2 hours time window (Figure 3.2).
The optical probe3 consisted of one DCS source and three DCS detectors combined
with four DOS sources and one DOS detector, providing a total of three DCS source-
detector combinations (separated at 1.5, 2.0, and 2.5 cm), and four DOS source-detector
combinations (separated at 1.5, 2.0, 2.5 and 3.0 cm) (Figure 3.1). In this work, we opted to
focus on a single DCS source-detector separation (2.5 cm) and only two DOS wavelengths
(690 and 846 nm). With these separations, we were capable of probing the most external
surface of the prefrontal cortex (PFC), as it was shown in previous studies [24, 144].
3The optical probe was a small rubber pad of approximately 2× 5 cm.
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Figure 3.1: Instrumentation utilized for the study inside a intensive care unit. (A) The
diffuse optical system, which combines a frequency-domain diffuse optical spectroscopy
(DOS) module and a diffuse correlation spectroscopy (DCS) module. (B) A schematic of
the optical probe employed in this study, which consisted of three DCS source-detector
separations (1.5, 2.0 and 2.5 cm, in red) and four DOS source-detector separations (1.5,
2.0, 2.5 and 3.0 cm, in black). The optical probe was a small rubber pad of approximately
2×5 cm. This figure is part of a manuscript we recently submitted to Frontiers in Medicine
[143].
Figure 3.2: Real-time graphical user interface (GUI) for the developed diffuse optical
system. The interface display the real-time information of cerebral blood flow (CBF),
oxygen saturation (StO2) and cerebral metabolic rate of oxygen (CMRO2), in a 5 minutes
time window on the left, and in a 2 hours time window on the right.
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3.1.4 Optical analysis
We employed a multi-spectral fitting algorithm to analyze the FD-DOS data. Briefly, we
use a non-linear fitting procedure to compare the measured light intensity (ACMeas) and
phase (PhMeas) to the theoretical light intensity (ACTheo) and phase (PhTheo) extracted
from the solution of the diffusion equation assuming a semi-infinite homogeneous medium
(Equation 2.8). In our approach, all DOS source-detector separations at all wavelengths
were fit simultaneously to recover the HbO and HbR concentrations as well as the scat-
tering parameters A and b using Equations 2.17 and 2.18, and we assumed constant water
concentration fraction fH2O = 0.75. We used the Nelder-Mead non-linear least squares
algorithm to minimize the cost-function:
χ2 = χ2Ph + χ
2
AC , (3.1)
where
χ2AC =
∑
λ
∑
ρ1
∑
ρ2
ρ2 6=ρ1
log
(
ACMeas(ρ1, λ)
ACMeas(ρ2, λ)
)
− log
(
ACTheo(ρ1, λ)
ACTheo(ρ2, λ)
)
(3.2)
and
χ2Ph =
∑
λ
∑
ρ1
∑
ρ2
ρ2 6=ρ1
(PhMeas(ρ1, λ)− PhMeas(ρ2, λ))− (PhTheo(ρ1, λ)− PhTheo(ρ2, λ)) .
(3.3)
To improve the stability of our fitting procedure, we first calculated the average scattering
coefficients (i.e., A and b) from either the initial or the last 10 minutes of data (depending
on the hemisphere placement order). Then, using the fixed parameters for A and b, we
computed the HbO and HbR concentrations from each time point.
For the DCS analysis, we first estimated the absorption and scattering coefficients at
the DCS wavelength (i.e., 785 nm) using the parameters recovered from the multi-spectral
fit of our DOS data. Then, we fit the measured autocorrelation function to a semi-infinite
homogeneous dynamic model to recover a BFI (Equation 2.16). For the DCS data, each
source-detector separation was fit independently [13]. All analysis scripts were written
using open-source libraries based on Python 3 [145–147].
Tissue oxygen saturation (StO2) was calculated as the fraction of HbO considering all
hemoglobin concentrations (i.e., StO2 = HbO/HbT , where HbT = HbO+HbR). Oxygen
extraction fraction (OEF) was computed as OEF = (SaO2 − StO2)/(γ ∗ SaO2), where
SaO2 is the arterial blood oxygen saturation, and γ is the percentage of blood volume
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contained in the venous compartment of the vascular system, assumed to be 0.75 [30, 63].
From CBF and OEF, the cerebral metabolic rate of oxygen (CMRO2) can be estimated
as CMRO2 = Hgb ∗ CBF ∗ OEF [30, 31, 63]. All neurophysiological parameters were
calculated for each time point continuously every 6 seconds.
Since systemic physiological data (MAP, SaO2 and Hgb) were recovered from the
medical records (which were collected every 2 hours), we only report the average data
points of each neurophysiological parameter calculated across each optical monitoring
session. This procedure allowed us to compare data from different sources. The error
bars in the plots represent the standard deviation of the data across the time-window
used for averaging.
3.2 Results
3.2.1 Cerebral hemodynamics of a subarachnoid hemorrhage pa-
tient monitored during hospitalization
We first report on the case of a 62-years-old female who was admitted to the neuro
intensive care unit after a severe headache for 3 days associated with nausea, vomiting
and elevated blood pressure. She rapidly progressed to coma right after admission. The
first CT scan after admission revealed a right middle cerebral artery (MCA) aSAH with
a Grade V on the Hunt & Hess scale (i.e., predicting a poor outcome and a low likelihood
of survival, see Table A.1) [148] and Grade III on the Fisher Scale (i.e., low to high risk
of vasospasm4, see Table A.2) [149]. The TCD measurement performed on the first day
of hospitalization did not show any signs of vasospasm (mean CBFv of 73 cm/s and 83
cm/s, for the right and left MCA, respectively).
We started monitoring the patient with our diffuse optical system on the second day
following admission, approximately 32 hours after hospitalization. At that time, MAP
was 90 mmHg and we found lower CBF and CMRO2 on the ipsilesional sideof the PFC
when compared to the contralesional side 5 , consistent with lower metabolism following a
brain hemorrhage. The OEF and the total hemoglobin concentration (HbT, which is pro-
portional to cerebral blood volume) was similar between the two hemispheres. Figure 3.3
shows the daily averages of all the cerebral measurements obtained with our diffuse opti-
4Vasospasm is a sudden constriction of a blood vessel, reducing its diameter and flow rate.
5The ipsilesional side is the hemisphere on the side of the lesion, while the contralesional side is the
opposite hemisphere.
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cal system along with the mean arterial pressure and the CT scans performed during the
whole hospitalization period. Shortly after the first optical monitoring session, the patient
underwent an emergency ventriculostomy with EVD placement due to high intracranial
pressure.
On the third day of hospitalization, during the second optical monitoring session, a
large increase in MAP was observed (up to 122 mmHg), associated with an overall increase
in CBF and CMRO2. The increase in CBF and CMRO2 was comparatively higher in the
ipsilesional side. In addition, an increase in ipsilesional OEF and a decrease in ipsilesional
HbT were also measured, suggesting high metabolic demand due to low blood availability
in tissue. The CT scan obtained in the fourth day after admission revealed an extensive
ischemic area on the ipsilesional hemisphere. The TCD performed in the fourth day found
mean CBFv of 64.2 and 68.3 cm/s on the right and left MCAs, respectively. In the fourth
day of hospitalization, the patient evolved with non-photo reacting pupils and absent
corneal reflex. The clinical examination remained unchanged even after analgesic and
sedative drug withdrawal. With this prognostic, the clinical staff opted for comfort care.
Due to intermittent clinical care to assist the patient, no optical monitoring was taken
between the fourth and the fifth days.
On the sixth day of hospitalization, during the third optical monitoring session, OEF
was below 40% in both hemispheres. Compared to the first optical monitoring session,
CBF increased by 40 and 51% in the ipsilesional and contralesional sides, respectively.
However, the increase in CBF was not followed by any significant changes in CMRO2
(Figure 1). From the second to the sixth day after hospitalization, HbT increased in the
contralesional side and decreased in the ipsilesional side. MAP at the sixth day was 85
mmHg.
For the following two days, ipsilesional CBF and CMRO2 further decreased, respec-
tively, by 82 and 69% (compared to day 6), and OEF dramatically increased by approx-
imately 76%. Cerebral blood volume (CBV), as estimated by HbT) decreased in the
contralesional side, reaching the levels of CBV in the ipsilesional side. The ipsilesional
CBV remained relatively stable between the second and ninth day of hospitalization. The
patient died on the ninth day after hospitalization. MAP decreased to 67 and 45 mmHg
during the last two monitoring sessions, respectively.
The differences between the ipsilesional and the contralesional sides over the entire
period can be more directly analyzed by computing the laterality index (LI) for each
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Figure 3.3: Evolution of the brain lesion in a 62 years old female patient following a high-
grade aneurysmal subarachnoid hemorrhage (aSAH). (A) Neurophysiological parameters
measured with the diffuse optical system, as well as the systemic mean arterial pressure
(MAP). (B) Computed tomography (CT) images at different days during hospitalization
(marked as vertical lines in the left panel). The patient died in the ninth day after
hospitalization. The red areas in the CT images represent the optical sensitivity region.
The error bars of each point represent the standard deviation of each parameter across
the monitoring time-window. For some days, the standard deviation was too small to be
shown. CBF: cerebral blood flow; OEF: oxygen extraction fraction; CMRO2: cerebral
metabolic rate of oxygen; HbT: total hemoglobin concentration. This figure is part of a
manuscript we recently submitted to Frontiers in Medicine [143].
physiological parameter:
LI =
Xipsi −Xcontra
Xipsi +Xcontra
, (3.4)
where X represents the parameter measured, and the subscript denotes the brain side.
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Figure 3.4: Temporal evolution of the laterality index for the optically derived physi-
ological parameters in a 62 years old female patient following a high-grade aneurysmal
subarachnoid hemorrhage (aSAH). The changes in the ipsilesional hemisphere compared
to the changes in the contralesional hemisphere are shown in the left axis for cerebral
blood flow (CBF, red circles), oxygen extraction fraction (OEF, blue diamond) and cere-
bral metabolic rate of oxygen (CMRO2, green triangles). Evolution of the mean arterial
pressure (MAP, gray squares) are shown in the right-axis for comparison. The error bars
of each point represent the standard deviation of each parameter across the monitoring
time-window. For some days, the standard deviation was too small to be shown.
Figure 3.4 shows the LI evolution over time for the patient following aSAH for all the
hemodynamic and metabolic parameters provided by the optical system. Careful analysis
of Figure 3.4 reveals two significant periods of hemispheric impairment. The first period
occurred between the first and the third days after hospitalization, in which all the neuro-
physiological parameters in the ipsilesional PFC increased more than in the contralesional
side. After the third day of hospitalization, the LI continuously decreased on the following
days, consistently with the worsening of the patient condition.
3.2.2 Cerebral hemodynamics of a severe ischemic stroke patient
In order to further illustrate the capability of diffuse optical methods in the neuro-ICU
in a wide range of neurological injuries, we also report on another case with a different
stroke etiology and clinical outcome. The patient is a 50-years-old female with a history
of diabetes, hypertension, and congestive heart failure, who presented with left sided
hemiparesis and was found to have an ischemic stroke due to an occlusion on the right
MCA with a National Institute of Health Stroke Scale (NIHSS) of 11 (i.e., a moderate
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Figure 3.5: Neurophysiological information of a patient diagnosed with severe ischemic
stroke on the right middle-cerebral artery at the thirteenth day after hospitalization. (A)
Cerebral blood flow (CBF), oxygen extraction fraction (OEF), cerebral metabolic rate of
oxygen (CMRO2) and total hemoglobin concentration (HbT) measured with the diffuse
optical system in the contralesional and the ipsilesional hemispheres. (B) Computed
tomography (CT) scan from the single-day measurement of the patient. The red areas in
the CT images represent the optical sensitivity region.
stroke, see Table A.3) [150]. Figure 3.5 shows the patient optical-derived parameters and
the CT scan at the thirteenth day after hospitalization, while the patient was intubated
and sedated. The CT image on the thirteenth day revealed an extensive ischemia on
the right hemisphere. During this single monitoring session, CBF, CMRO2 and HbT in
the ipsilesional hemisphere were considerably lower than the contralesional hemisphere,
consistent with a perfusion deficit and subsequent tissue necrosis caused by the large
ischemia. Additionally, OEF in the ipsilesional hemisphere was 27% higher than OEF
in the contralesional side, possibly reflecting the high demand of the surrounding tissue
due to low blood availability in the affected hemisphere. During the monitoring period,
the patient’s arterial blood pressure was 129/65 mmHg. Ultimately, this patient was
discharged after 42 days of hospitalization with severe residual deficits.
3.3 Discussion
Diffuse optics has been previously validated in different clinical settings as an alternative
bedside monitoring tool, and it holds potential to personalize clinical management. De-
spite limitations in the penetration depth inherent to any diffuse optical technique [13, 17,
144], both DCS and DOS are capable of monitoring cerebral hemodynamics noninvasively
and in real-time, without the use of exogenous contrasts, ionizing radiation, and without
interfering with the current clinical practices. Unlike global systemic physiological mon-
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itors, the principles of light propagation limit the measurement to a region of interest,
which can be useful to monitor specific regions such as an ischemic penumbra6 or the
region around a local brain injury. In addition, due to its portability and low cost, diffuse
optical methods can be very useful to clinicians in places where clinical care conditions
are restricted, such as during sports, in military fields and in developing regions. In these
scenarios, access to other neuroimaging tools are very limited. Even in better clinical con-
ditions, access to daily neuroimaging data for longer periods of time may not be readily
available.
In this work, we report on results from two representative case-studies as part of
translating a diffuse optical system to the neuro-ICU. For simplicity, we limited our mea-
surements to the forehead, and thus we were only sensitive to focal changes in the PFC,
which turned out to be sufficient to elucidate the main events during the evolution of the
patient’s brain injury. Here, we focused on the feasibility of performing longitudinal mea-
surements in the neuro-ICU with the optical device. For this reason, to reduce possible
interference with clinical interventions, we opted to minimize both the size of the optical
probe and the monitoring time per day. However, we note that these choices are not in-
trinsic limitations from the optical system. The optical probes are small and customized
so that they can be temporarily detached from the patients for any necessary reason.
Since our optical system measures absolute concentration, we are not limited to a base-
line or reference period. Also, the system’s high portability allows its relocation alongside
the patient with minimal time and effort. Concerning the duration of the measurement,
long-term continuous monitoring (i.e., several hours per day) poses no extra-challenge in
the present system. In fact, previous studies have reported optical measurements with
a similar optical system for as long as 8 hours per day, both in adults [47, 50] and in
neonates at the ICU [151].
The first observational case report presented in this work concerned a patient severely
affected by aSAH, who was admitted almost three days after the event. Optical measure-
ments obtained with DCS/DOS were consistent with the triphasic evolution of aSAH:
hypoperfusion, hyperemia, and vasospasm [152, 153]. To the best of our knowledge, this
is the first report on DCS/DOS long-term monitoring during the different phases following
aSAH.
During the first day of monitoring, the patient had poor ipsilesional CBF and CMRO2
but normal OEF when compared to the contralesional side, consistent with a hypoperfu-
6Ischemic penumbra is an ischemic tissue potentially destined for infarction but that is not irreversibly
injured.
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sion phase. In a previous PET study, Yundt et al. found similar trends of reduced CBF
and CMRO2, but unaffected OEF, during the early phases of aSAH [154, 155]. This pat-
tern of low CBF and CMRO2 but unaffected OEF may be related to an ongoing ischemia,
to the start of the vasospasm phase or to a sign that the injury-related neurologic deficits
have not yet peaked. Based on the first CT scan (collected prior to our first monitoring
session, Figure 3.3), our results are most likely related to an ongoing ischemia. The initial
aSAH insult (i.e., blood in the subarachnoid space) may impact mitochondrial function
and diminish oxidative metabolism in favor of anaerobic metabolism [156], which may
further explain our findings of low CBF and CMRO2, but unaffected OEF.
At the third day after hospitalization, we found an increase in OEF at the ipsilesional
side, which was associated with a bilateral increase in CBF and CMRO2 (with a compar-
atively higher ipsilesional increase, Figure 3.4). Previously, Yokose et al. found decreased
ipsilesional oxygen saturation (which corresponds to increased OEF) in severe aSAH pa-
tients with angiographic vasospasm with TD-DOS [157]. Thus, the higher OEF during
the third day after hospitalization could be an indicative of vasospasm. The fact that
the patient evolved to a severe ipsilesional ischemia between the fourth and fifth days is
another indicative of vasospasm. Taken together, our results corroborate Yokose et al.’s,
and reinforces the argument that decreases in tissue oxygenation (or, similarly, increases
in OEF) may be a more sensitive measure of vasospasm than blood velocity in large ar-
teries measured by TCD. Of note, prolonged elevation of ICP may also induce ischemia
in aSAH patients; in this study we did not assess ICP, therefore we cannot confirm the
real cause for ischemia in this patient.
We also measured increased CBF and decreased OEF in the contralesional side of
the patient between the second and the sixth days following hospitalization. During these
measurements, there was no significant difference in MAP. The increase in CBF with lower
OEF is indicative of cerebral hyperemia that may have been secondary to an inflamma-
tory mediated process causing significant vasodilation of the microvascular bed (therefore
increasing CBF and HbT) [156, 158]. The cerebral hyperemia in the contralesional side
may also be explained by an attempt to restore metabolic balance in the affected tissue.
However, by this time the patient had already developed a large ischemic insult, and only
the healthy tissue was capable of increasing CBF and appropriately oxygenating the tis-
sue. Additionally, the ipsilesional ischemia may explain the fact that CBV (as measured
by HbT) remained approximately constant across the different monitoring days (besides
the first monitoring session).
In addition to the neurophysiological parameters, the possibility to probe hemispheric
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impairment can provide extra information to the patient’s condition. The laterality index
has been shown to be very useful for different clinical scenarios [159–162], and it can be
readily assessed with the optical system by measuring both hemispheres. In the specific
case of the aSAH patient, the LI revealed different dynamics during the period of hos-
pitalization (Figure 3.4). The increase in LI at the third day after hospitalization could
be indicative of a possible homeostatic attempt to restore the metabolic balance of the
affected tissue. Similarly, the continuous decrease in the LI after day 3 is likely to reflect
the worsening condition of the patient.
To further illustrate the general potential of diffuse optics in the neuro-ICU, we also
presented a single-day study of a patient diagnosed with a severe ischemic stroke. In
this case, we found a large CBF mismatch between the ipsilesional and the contralesional
hemispheres (Figure 3.5), in agreement with the CBF mismatch from the aSAH patient
after the development of cerebral ischemia. Notably, although CBF was lower on the
ipsilesional hemisphere, we found high OEF in both hemispheres, which was comparatively
higher on the ipsilesional hemisphere. This may be consistent with the idea of misery
perfusion, a state in which there is high oxygen consumption (high OEF) despite low
(but non-zero) CBF as the tissue attempts to promote recovery [50, 154, 162]. Currently,
misery perfusion is hard to diagnose, and a larger study with acute ischemic stroke patients
is needed in order to assess the feasibility of detecting misery perfusion with diffuse optical
methods. Regardless, the second case study evidences the consistency and reproducibility
of the results obtained with the diffuse optical measurements across different patients
with different acute cerebrovascular diseases, and it further illustrates the potential of
the technique to provide neurointensivists with accurate noninvasive neurophysiological
information.
Overall, the results from the pilot observational case study presented here provide
evidence that neurophysiological information derived from DOS and DCS is consistent
with patient’s clinical condition following different stages of an aSAH patient, as well
as in an ischemic stroke patient. The optically-derived hemodynamic parameters were
sensitive to the mismatch between the physiology of the ipsilesional and contralesional
sides. We note, though, that further clinical studies with larger populations are needed to
analyze the accuracy of the technique to find specific events, and/or to measure the effects
of potential treatments on the patient’s cerebral physiology. Together, our results reinforce
that diffuse optics may provide useful information at the patient’s bedside which could aid
clinicians to make decisions based on the patient neurophysiology. The real-time access to
patient’s physiological condition may positively impact clinical care and therefore patient
outcome [163–165]. In addition, our results show the feasibility of performing diffuse
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optical monitoring in a restricted environment in a developing country where access to
other methods of cerebral monitoring are not always readily available.
Even though the optical results show strong agreement with clinical outcome, it is
worth noting that the optical parameters can be more accurate. In this work we modeled
the head as a semi-infinite medium for the DCS/DOS data analysis. By using the simplest
model for analysis in order to get real-time monitoring, our results do not account for
extracerebral contributions. Thus, it is likely that we have underestimated the cerebral
physiology changes in CBF, HbT, OEF and CMRO2 [14, 17, 144, 166]. In the future,
multi-layer models can be used to isolate extracerebral contributions to the optical signal
(for more information, see Chapter 5 and [20, 166–172]). However, these models either
require an extra step in the monitoring setup or may not yet be reliable for clinical
use. Nonetheless, the quantification of the neurophysiological changes does not affect
the comparison between hemispheres, since extracerebral contributions are expected to
similarly affect both the ipsilesional and the contralesional hemispheres.
3.4 Conclusion
To summarize, in this study we presented two observational case reports recorded dur-
ing the translation of a hybrid diffuse optical system for real-time monitoring of cerebral
hemodynamics inside a neuro-ICU. Our results suggest that optics may provide support-
ing information to monitor secondary damage following brain injury, and that optics can
be safely and noninvasively applied early during hospitalization, at the bedside with min-
imal interference with standard clinical practices. The optically-derived hemodynamic
parameters provide neurophysiological information at the microvasculature, which was
consistent with the clinical outcome. Although we focused on two representative cases,
our results support that diffuse optics can be a reliable tool for bedside monitoring and
encourage further clinical validations with DCS/DOS in the neuro-ICU. Translation of
diffuse optics to these settings can positively impact clinical care and patient outcome
and can be especially useful in low-budget hospitals and in remote areas, where cerebral
physiology monitoring is essential but not readily available.
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Chapter 4
Cerebral optical monitoring of
endovascular treatment of stroke
Mechanical thrombectomy has revolutionized treatment of patients with acute ischemic
stroke due to large vessel occlusion, by providing rapid restoration of blood flow to is-
chemic brain tissue [173, 174]. Briefly, the mechanical thrombectomy procedure involves
threading a catheter through the femoral artery to reach the clot in the cerebral artery
and then mechanically remove it. Currently, procedural success for mechanical thrombec-
tomy is defined by the degree of vessel recanalization visualized by angiography, most
often using the modified treatment in cerebral ischemia score (mTICI, see Table A.4 for
more details) [175, 176]. However, only about one-third of patients experience complete
recanalization. The majority are left with some degree of residual cerebral hemodynamic
impairment [173], which in turn correlates with infarct growth and greater long-term
disability [177]. Moreover, the degree of large artery recanalization, an anatomic struc-
tural observation, does not always reflect parenchymal cerebral blood flow (CBF) [178–
180], and this physiological factor holds potential to better predict infarct volume [178],
clinical outcome [180], and inform medical management strategies. Currently, there is
no suitable tool to measure CBF during mechanical thrombectomy in real-time, thus a
continuous bedside monitor has potential to impact patient care.
Transcranial optical monitoring during mechanical thrombectomy has been carried
out recently with commercial CW-DOS (or NIRS) instrumentation [46, 83]. While en-
couraging, these studies only found small changes in oxygen saturation, and the results
did not necessarily correlate with outcome. Importantly, in these studies, the commercial
NIRS systems may not have offered the most sensitive measure of change in the con-
text of recanalization. Commercial NIRS may not accurately distinguish scalp and brain
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changes, and direct CBF monitoring with DCS, which is not possible with NIRS, may be
a more sensitive tool for probing physiological changes during mechanical thrombectomy.
The DCS blood flow signal is weighted towards comparatively (e.g., compared to NIRS)
longer photon paths [144, 181] that penetrate more deeply into the brain. Additionally,
the relative difference between intracerebral and extracerebral flow is greater than the
relative difference in oxygen saturation between these two compartments. Therefore, it is
likely that optical monitoring of CBF using DCS is inherently more sensitive to cerebral
physiology changes than commercial NIRS systems [14, 17, 138, 144, 182].
In this chapter, we will describe our previously published study regarding the use
of DOS and DCS for real-time monitoring of bilateral frontal lobe microvascular CBF
during and after recanalization [142]. This work documented important first steps to-
wards establishing continuous diffuse optical monitoring of cerebral microvasculature as a
means for non-invasive, patient-specific quantification of tissue-level reperfusion following
mechanical thrombectomy.
4.1 Methods
4.1.1 Subject recruitment
Between December, 1, 2017 and July, 2, 2018, we monitored 7 patients as part of an
ongoing protocol to evaluate the safety and efficacy of transcranial optical monitoring
during mechanical thrombectomy. More specifically, we monitored patients undergoing
mechanical thrombectomy to treat acute ischemic stroke caused by unilateral occlusion
of the cerebral arteries at the Hospital of the University of Pennsylvania. In total, we
monitored 5 patients with unilateral middle-cerebral artery (MCA) occlusions, and 2 pa-
tients with unilateral internal carotid artery (ICA) occlusions. Since we were restricted to
measurements on the forehead in this study, and since measurements on the forehead may
not be sensitive to all MCA occlusions, herein we focus on and describe only preliminary
results from two ICA occlusion patients. In both cases, mechanical thrombectomy was
performed under general anesthesia. Endotracheal intubation occurred immediately prior
to the initiation of optical monitoring, and mechanical ventilation continued throughout
the course of the monitoring protocol.
The study was carried out in accordance with the Belmont Report with written
informed consent from all subjects (or legally authorized surrogate). Given the time-
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sensitive nature of mechanical thrombectomy and the non-significant risk associated with
this research protocol, written informed consent was obtained retrospectively. The proto-
col was approved by the University of Pennsylvania Institutional Review Board (Protocol
Number 828249).
4.1.2 Experimental protocol
Eligible patients were identified by a vascular neurologist. In accordance with standard-
of-care, patients were transported to the interventional neuroradiology suite in order to
perform mechanical thrombectomy. After the patient was situated on the procedure table,
optical probes were placed bilaterally on the lateral aspect of the forehead (Figure 4.1).
To optimize the optical signal, care was taken with probe placement to avoid hair and
frontal sinuses. The probes were fixed to the head with double-sided tape and an elastic
bandage. Once the probes were secured, the light sources were turned on, and cerebral
hemodynamic data was collected throughout the course of the mechanical thrombectomy
procedure.
Patients routinely remained on the procedure table for several minutes after completion
of the thrombectomy, and optical data collection continued during this time. Just prior
to removing the patient from the procedure table, data collection was stopped, and the
optical probes were removed from the patient’s head. The TD-DOS IRF measurement
was then carried out in a manner described elsewhere [114, 115]. MAP data was recorded
once every minute and were retrospectively retrieved from the anesthesia record and
time-synced with optical data. MAP was monitored either with an invasive catheter or a
brachial cuff, depending on clinical availability.
4.1.3 Optical instrumentation
For this study, we developed a hybrid diffuse optical instrument that combines a home-
made TD-DOS and a homemade DCS module (Figure 4.2-A). The TD-DOS module con-
tains two pulsed lasers (BHLP-700, Becker&Hickl, Germany) emitting short light pulses
(∼100 ps) at a 50 MHz repetition rate and operating at different wavelengths (685 and
830nm), one hybrid photomultiplier tube (HPM-100, Becker&Hickl, Germany), and a
TCSPC board (SPC130, Becker&Hickl, Germany). The DCS system contains 16 single-
photon counters (SPCM-AQ4C, Pacer, USA) connected to a fast software correlator [137],
as well as two long-coherence-length source lasers emitting light at 785nm (DL785-100-SO,
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Figure 4.1: Schematic of the experimental setup for monitoring mechanical thrombectomy.
After the patient was situated on the procedure table, two fiberoptic optical monitoring
probes were placed on the lateral aspect of the forehead, bilaterally. Groin access and
mechanical thrombectomy proceeded without delay. Microvascular cerebral blood flow
(CBF), oxy-hemoglobin concentration, and deoxy-hemoglobin concentration were simul-
taneously monitored on the ipsilateral hemisphere with Diffuse Correlation Spectroscopy
(DCS) and Time-Domain Diffuse Optical Spectroscopy (TD-DOS). A notch filter (cen-
tered at 785 nm) was placed in front of the TD-DOS detector to facilitate simultaneous
TD-DOS/DCS measurements. On the contralateral hemisphere, CBF alone was moni-
tored with DCS. This figure was extracted from our previously published study [142].
CrystaLaser, USA).
To permit simultaneous TD-DOS/DCS measurements, we introduced a fiber-coupled
notch filter centered at 785 nm before the TD-DOS detector to block light from the DCS
source (OZ Optics, Figure 4.1). Data acquisition was controlled with custom-written
software in the LabVIEW environment (National Instruments, USA), with an interface
based on current clinical monitors (similar to the interface from Chapter 4). The data
acquisition rate was 20 Hz for DCS and 0.7 Hz for TD-DOS. For DCS, we employed two
source-detector separations on each hemisphere: one short separation (0.7 cm) primarily
sensitive to extra-cortical tissue, i.e., scalp and skull, and one long source-detector sepa-
ration (2.5 cm), which has been shown to provide acceptable SNR and cortical sensitivity
[17, 144, 182]. Since we were limited to use of a single TD-DOS detector, the TD-DOS
measurement was made with a single, large source-detector separation (3.2 cm) on the
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Figure 4.2: Instrumentation used to measure the cerebral hemodynamics of patients dur-
ing mechanical thrombectomy. In (A) we show the instrument utilized in this study, which
consisted of a time-domain diffuse optical spectroscopy (TD-DOS) module and a diffuse
correlation spectroscopy (DCS) module. For simultaneous TD-DOS and DCS measure-
ments, we used a notch filter (785 nm). (B) We created two rubber pad (∼ 2 × 5 cm)
to hold the optical fibers bilaterally on the forehead. The probes were fixed to the head
with double-sided tape and an elastic bandage. Each probe consisted of two separations
for DCS and one separation TD-DOS. However, we were only measured with TD-DOS
on the hemisphere ipsilateral to the occlusion.
hemisphere of interest, i.e., ipsilateral to the occlusion1. We created a rubber pad (∼ 2×5
cm) to hold the optical fibers on the forehead (Figure 4.2-B and C).
4.1.4 Optical analysis
The temporal decay of the DCS autocorrelation function, and therefore the recovered
CBF indices, are sensitive to the optical properties of the underlying tissues. Thus, to
improve DCS accuracy, we estimate the tissue absorption and reduced scattering coeffi-
1The ipsilateral hemisphere is the hemisphere on the same side as the occlusion.
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cients independently with TD-DOS (for more details about TD-DOS see Section 2.2.1.4
and [59, 104, 109, 141]). For each TD-DOS wavelength, λ, we fit the baseline-averaged
DTOF (i.e., averaged over ∼ 5 minute interval before the initiation of cerebral vasculature
manipulation) to a convolution of the TD-DOS IRF and the semi-infinite Green’s function
solution of the photon diffusion equation. This enables the calculation of baseline tissue
absorption and reduced scattering coefficients, i.e., µa,o(λ) and µ′s,o(λ), along with the
effective launch time of the incident source pulse on the tissue (To) [59, 109]. Thereafter,
the DTOF acquired at every measurement time was fit to derive an absorption coeffi-
cient, µa(λ); these fits assumed constant reduced scattering coefficient and constant To
(both were derived from baseline fit). The multispectral tissue absorption measurements
also assume a water volume fraction of 0.75 (Equations 2.17 and 2.18). The scheme per-
mits recovery of HbO and HbR concentrations at every time-point. This information, in
turn, enables calculation of the tissue absorption and scattering coefficients at the DCS
wavelength (785 nm) using the chromophore extinction coefficients [62].
To help distinguish between intracerebral and extracerebral blood flow changes, we em-
ployed a multi-distance DCS measurement. An approximate rule of thumb, which we will
utilize in our thinking and analysis, is that the short source-detector separations measure
exclusively extracerebral blood flow changes, while the long source-detector separations
measure relative changes of cerebral blood flow (rCBF).
To improve the signal quality, we first down-sampled the DCS data by averaging se-
quential sets of two temporal autocorrelation curves measured by DCS. Then, to recover
the blood flow changes, we separately fit the autocorrelation curves for each separation us-
ing a semi-infinite homogenous tissue model (Equation 2.16). We use a baseline-averaged
autocorrelation curve (averaged over ∼ 5 minutes before the initiation of cerebral vas-
culature manipulation) to recover the coherence factor in the Siegert relation (β) [125].
Next, we fit every frame for the DCS blood flow index, assuming that β remains constant
throughout the experiment. Finally, to reduce the effects of systemic physiological varia-
tions, the data was low-pass filtered using a Butterworth filter with a cutoff frequency of
0.0167 Hz. All analysis scripts were written using open-source libraries based on Python
3 [145–147].
4.2 Results
Patient 1 presented with acute onset aphasia and right hemiplegia, with admission a
NIHSS of 24 (i.e., a severe stroke, Table A.3). The patient was not eligible for intra-
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Table 4.1: Baseline, procedural, and outcome summary.
Patient 1 Patient 2
Baseline
Age 80-85 60-65
NIHSS 24 15
Vessel occlusion left cervical ICA right cervical ICA
ASPECTS 8 7
Infarct core (cc) * 5 19
Penumbra (cc) * 187 97
Procedural details
Time from onset to re-
canalization (min)
196 278
Final mTICI score 2b 2b
Early complications None Difficulty achieving revascularization
in context of ICA dissection
Late complications None Edema and hemorrhagic conver-
sion necessitating decompressive
hemicraniectomy
Outcome
Discharge NIHSS 1 17
Discharge disposition Home Rehabilitation
*based on CT perfusion imaging analysis by RAPID software (iSchemaView, Inc., USA).
Infarct core is defined by CBF < 30%. Penumbra is defined by Tmax > 6 seconds.
venous thrombolysis because of oral anticoagulation use. The patient was transferred for
consideration of mechanical thrombectomy; initial imaging revealed left ICA occlusion
with patent intracranial circulation. Left hemisphere appeared to be filling via anterior
communicating artery. CT perfusion identified a large territory at risk of infarction.
While CT suggested a cervical ICA occlusion, catheter angiogram identified the occlusion
in the intracranial ICA segment. Slow proximal flow created the false appearance of a
more proximal occlusion on non-invasive imaging. Successful recanalization (mTICI 2b,
see Table A.4) was achieved with a single pass of a SolitaireTMstent retriever (Medtronic
PLC, USA). Table 4.1 summarizes the patient’s clinical details. Figure 4.3 shows relevant
neuro-imaging studies, i.e., CT perfusion/structural images and angiograms, before and
after mechanical thrombectomy. For this patient, MAP was recorded non-invasively at
the beginning of the procedure, but eventually, an invasive catheter was inserted (radial
artery) for continuous blood pressure monitoring during a portion of the procedure.
At the time of recanalization, a large increase in optically measured rCBF was observed
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Figure 4.3: Imaging before and after mechanical thrombectomy (Patient 1). Baseline CT
perfusion as analyzed by RAPID software (iSchemaView, Inc. Redwood City, CA) indi-
cates (A) a small infarct core in the left hemisphere, as defined by Cerebral Blood Flow
(CBF), lower than 30% of the contralateral values, and (B) a large penumbra, as defined
by regions where the time to maximum (Tmax) of the residue function obtained by de-
convolution is higher than 6s. (C) Angiogram confirmed patency of left common carotid
artery and occlusion of the internal carotid artery (ICA). After mechanical thrombec-
tomy, an angiogram revealed (D) ICA recanalization, as well as (E) patent intracranial
circulation. (F) Follow-up CT identified a small left lateral frontal lobe infarction (red
circle). This figure was extracted from our previously published study [142].
in the affected hemisphere, with minimal change in extracerebral blood flow (Figure 4.4-
A). After recanalization, despite a large MAP fluctuation (from 64 to 110 mmHg), CBF
remained elevated, which could reflect intact autoregulatory mechanisms in the reperfused
cerebral tissue. In the contralateral hemisphere, we also observed a transient increase
in CBF at the time of recanalization, which returned to baseline after a few minutes
(Figure 4.4-B). No complications occurred during mechanical thrombectomy. Patient 1
experienced near complete resolution of her neurologic deficits and she was discharged on
hospital day 5 with an NIHSS of 1 (i.e., a minor stroke, Table A.3).
Patient 2 experienced several episodes of emesis and retching in the context of pre-
sumed gastroenteritis. Less than an hour following an episode of retching, the patient
developed severe right-sided neck pain followed by acute onset left hemiplegia2. The pa-
2Hemiplegia is the same as hemiparesis, i.e., a paralysis of one side of the body.
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Figure 4.4: Hemodynamics of recanalization (Patient 1). Optical flow monitoring re-
vealed a large and sudden increase in (A) ipsilateral CBF (red solid line, left axis) after
recanalization (green bar); this sudden increase was not mimicked by the extracerebral
tissue, which instead showed minimal blood flow changes at these times (black solid line,
left axis). We also observed a smaller transient (B) contralateral CBF increase. Despite
MAP fluctuations (blue dashed line, right axis), after recanalization CBF remained rela-
tively stable on both sides. The grey shaded region represents baseline period. This figure
was extracted from our previously published study [142].
tient presented with an NIHSS of 15 (i.e., a moderate to severe stroke, Table A.3) to
the local emergency room. The patient was treated with intravenous thrombolysis and
was transferred for consideration of mechanical thrombectomy. Upon arrival, the neuro-
logic deficit was unchanged, and imaging revealed right cervical ICA occlusion with intact
intracranial vasculature. Right hemisphere appeared to be filling via anterior communi-
cating artery. The patient’s clinical details are summarized in Table 4.1. Radiological
imaging is presented in Figure 4.5. For this patient, MAP was non-invasively monitored
by brachial cuff throughout the protocol. The decision was made to proceed with me-
chanical thrombectomy. Because of ICA dissection3 and associated occlusion, the ICA
was difficult to traverse, and after multiple attempts at angioplasty4, an ICA stent was
ultimately placed. There was no evidence of intracranial occlusion. When the ICA was
first manipulated, there was a steep decline in MAP (124 to 66 mmHg), which was likely
a consequence of carotid sinus disruption. This decline in MAP was accompanied by a
bilateral decrease (∼ 50%) in CBF and extracerebral flow (Figure 4.6). Blood pressure
was then augmented pharmacologically; this increased contralateral flow but failed to im-
prove blood flow on the side of the occlusion. Over the subsequent 15 minutes (prior to
successful stent placement), blood flow in the affected hemisphere fluctuated dramatically.
3An arterial dissection is a tear in the lining of an artery.
4Angioplasty is a surgical repair or unblocking of a blood vessel.
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Figure 4.5: Imaging before and after mechanical thrombectomy (Patient 2). Baseline CT
perfusion as analyzed by RAPID software (iSchemaView, Inc. Redwood City, CA) indi-
cates (A) small-to-moderate infarct core in the right hemisphere, as defined by Cerebral
Blood Flow (CBF) lower than 30% of the contralateral values, and (B) large penumbra, as
defined by regions where the time to maximum (Tmax) of the residue function obtained by
deconvolution is higher than 6s. (C) Angiogram confirmed right cervical ICA occlusion,
which was ultimately (D) recanalized after stent placement. (E) Follow-up CT identified
a very large right hemispheric infarction (red circle). This figure was extracted from our
previously published study [142].
More detailed inspection revealed that at times of low CBF, a near-total loss of pul-
satile flow is apparent, along with intermittent periods of flow restoration. However,
even with stable MAP on pressors, pulsatile flow in Patient 2 was not always maintained
(Figure 4.7). At the time of stent placement, ipsilateral CBF continued to fluctuate for
several minutes and slowly increased to almost 50% above the baseline value, despite
stable MAP. Another spike in MAP was accompanied by a large CBF spike to almost
double the baseline value. Notably, the intermittent loss of pulsatile flow was only seen
in the ipsilateral CBF and was first instigated by the significant decrease in MAP prior
to recanalization (Figures 4.6 and 4.7).
Immediate follow-up head CT showed evolved right hemispheric infarction along with
patchy hyperdensity throughout the hemisphere. This is suggestive of a combination of
contrast extravasation and some component of hemorrhage. The patient’s final infarct
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Figure 4.6: Hemodynamics of recanalization (Patient 2). Optics revealed a large and
gradual increase in (A) ipsilateral CBF (red solid line, left axis) after recanalization (green
bar), with minimal (B) contralateral CBF and extracerebral blood flow (black solid line,
left axis) changes (black solid line, left axis). Prior to recanalization, a large drop in MAP
(blue dashed line, right axis) was accompanied by a bilateral decrease ( 50%) in CBF and
extracerebral flow. Blood pressure was augmented pharmacologically, which resulted in
an increase in contralateral flow but failed to improve flow on the side of the occlusion.
Grey shaded region represents the baseline period. This figure was extracted from our
previously published study [142].
burden was very large, with associated edema and mass effect, necessitating decompressive
hemicraniectomy5 on hospital day 3. She was eventually discharged to a rehabilitation
facility on hospital day 24, with an NIHSS of 17 (i.e., a moderate to severe stroke, Ta-
ble A.3).
5Hemicraniectomy is a surgical procedure where a large flap of the skull is removed to decrease
intracranial pressure.
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Figure 4.7: CBF heart-rate pulsatility during mechanical thrombectomy. Ipsilateral (red)
and contralateral (black) CBF changes from Patient 2, before f]ltering. The Top panel
shows CBF changes across the whole experiment. The green bar indicates the time of
recanalization, and the grey shaded region indicates the baseline period. Each of the
three bottom panels exhibits fast (without filtering) time variation in one of the three red
shaded regions. These scaled zoomed-in versions of ipsilateral and contralateral CBF were
separated to show the difference in heart-rate pulsatility across the different hemispheres
and time. This figure was extracted from our previously published study [142].
4.3 Discussion
In this proof-of-concept study, we employed a noninvasive, contrast-free optical technique
to monitor frontal lobe hemodynamics at the bedside during mechanical thrombectomy.
To help distinguish between extracerebral and intracerebral blood flow changes, we ob-
tained data from short (0.7 cm) and long (2.5 cm) source-detector separations. In two
patients with cervical ICA occlusion, we measured an increase in ipsilateral CBF after
recanalization while detecting no significant changes in extracerebral flow. A more de-
tailed inspection of the CBF temporal response to mechanical thrombectomy revealed two
distinct hemodynamic responses which were associated with divergent clinical outcomes.
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Note, the DCS signal has contributions from arterial, capillary, and venous compartments.
If cerebral blood volume is not transiently changing, the total blood flow in each vascular
compartment is equal, and the precise compartmental contributions will not influence
the measurement. When blood volume is transiently changing, DCS is more sensitive to
arterial contributions [26, 126].
Patient 1 experienced a large and sudden increase in CBF after recanalization, which
was sustained over the remainder of the monitoring period (∼ 25 min). Notably, after
recanalization, CBF remained elevated despite a large MAP fluctuation (between 64 and
111 mmHg), perhaps reflecting intact cerebrovascular autoregulation. Although it is often
assumed that stroke impairs autoregulation [183], this assumption may not be true for
all brain regions or for all patients [184] and may be affected by anesthetic drug and
procedure factors [185]. In Patient 1, the large and sustained increase in CBF, and the
apparent intact autoregulation, likely reflects the hemodynamics of effectively salvaged
tissue. In fact, in a short interval follow-up, this patient made a quick and near-complete
recovery with a very small final infarct burden. This result suggests that continuous
monitoring of CBF with diffuse optics may facilitate individualized blood pressure goals
aimed at optimizing CBF.
Interestingly, at the time of ICA recanalization in Patient 1, a transient increase in
contralateral CBF was also observed. Prior to recanalization, this patient was perfusing
the left hemisphere via the right carotid system with right-to-left flow through a patent
anterior communicating artery. It is conceivable that this creates a “steal” phenomenon,
in which blood flow to the unaffected right hemisphere is reduced. After recanalization,
right to left flow through the anterior communicating artery is reduced and CBF in the
right hemisphere increases. Additionally, some of this change could be related to MAP,
which was elevated around the time of recanalization, and subsequently decreased ∼ 5
minutes following recanalization.
In Patient 2, we observed a more gradual increase in CBF after recanalization, along
with intermittent loss of pulsatile flow as seen by our fast DCS module on the ipsilateral
hemisphere, but not the contralateral hemisphere (Figure 4.7). In fact, the initial loss
of pulsatile flow coincided with a decline in MAP. These observations may indicate mi-
crovascular collapse in a low-flow state, perhaps enhanced by early infarct-related edema
or elevated vasomotor tone of smooth muscle in arterioles [26]. Interestingly, with MAP
augmentation, there was intermittent restitution of pulsatile flow. However, pulsatile
flow was not well sustained, and even with ICA recanalization, we did not detect sud-
den increases in CBF, perhaps reflective of persistent microvascular dysfunction. These
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observations highlight another potentially valuable application of these bedside optics,
i.e., to cases wherein the angiographic appearance of large vessel recanalization fails to
adequately describe the hemodynamic state of the tissue. Identification of microvascular
impairment after recanalization could enable clinicians to identify patients experiencing
“no-reflow”, which has long been a nebulous and challenging clinical phenomenon that is
associated with morbidity and mortality [186, 187].
In the case of Patient 2, the microvascular perturbation occurred in a patient that
ultimately suffered a very large infarction. It is not clear if the microvascular impairment
led to infarct expansion, or if the flow impairment was a consequence of the developing
infarction. The temporal relationship of CBF with hypotension supports the former hy-
pothesis, but conclusions should not be drawn from a single case. Ongoing studies will
help to define the incidence of this discordance between large artery and microvascular
flow and may identify additional hemodynamic patterns that occur with recanalization.
Ultimately, the ability to non-invasively assess tissue reperfusion before and after re-
canalization may aid clinicians to more quickly assess treatment efficacy and concurrent
physiologic management, such as blood pressure goals and head of bed angle.
It is also important to note that Patient 2 only achieved recanalization after extensive
ICA manipulation, including multiple angioplasty attempts, and eventual ICA stenting.
Some of the fluctuations before recanalization may reflect transient flow changes after
balloon angioplasty, but we could not reliably synchronize the optical signal with every
endovascular manipulation. In future studies, care will need to be taken to document
endovascular manipulation in detail, as this may influence CBF or, equally important, may
confirm that the hemodynamic changes are independent of endovascular manipulation. In
this initial feasibility study, monitoring was limited to the interventional radiology suite,
but continued monitoring in the ICU may present opportunities to further characterize
post-recanalization stroke physiology in future work.
Variations in anesthetic depth impact cerebral metabolism and possibly influence out-
come [188, 189], although clear clinical evidence of neuroprotection from anesthetics in
cerebral ischemia has proven elusive [190]. Unfortunately, we could not determine anes-
thetic depth due to a lack of EEG monitoring during the procedure. Anesthetic dose may
be abstracted from the anesthesia record, but it only crudely approximates the depth of
anesthesia. Furthermore, it is challenging to draw any conclusions regarding the impact
of cerebral metabolism changes due, in part, to limitations of steady-state modeling. No-
tably, both anesthesia and evolving ischemic conditions influence cellular metabolism, nei-
ther of which are static variables. Nevertheless, the observed sudden asymmetric changes
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in flow are not likely the effect of anesthesia, since anesthesia effects would likely be more
diffuse.
One limitation of DCS is that hair can disrupt the DCS signal and delay probe place-
ment; thus, measurements in this study were restricted to anterior frontal lobe. Given
this limitation, care was taken to place the probes on the lateral aspect of the forehead. In
this position, diffuse optics likely measures a combination of ACA and MCA flow, rather
than exclusively MCA flow. This situation presents less of a problem for patients with
ICA occlusion, but it may be an important consideration when monitoring patients with
MCA occlusion in whom we expect reduced sensitivity to parenchymal changes. CT per-
fusion imaging that is now routinely obtained in acute stroke patients may help identify
patients in whom flow impairment can be detected using frontally placed optical probes.
Ultimately, with more reliable and rapid DCS systems capable of transcranial monitoring
through hair, a more targeted placement of the optical probes over tissues of primary
interest will be possible.
Similarly to the previous chapter (Chapter 3), a potential limitation of our study is the
use of a SI homogenous medium tissue model for light transport, which may underestimate
CBF changes [14, 17, 144, 166, 182]. Furthermore, light detected by the long source-
detector separation is also sensitive to extracerebral changes, as these photons traverse the
extracerebral tissues before reaching the intracerebral tissues. This could lead to erroneous
interpretation of extracerebral blood flow changes as CBF changes. Nonetheless, by using
multi-distance measurements, our results demonstrated that mechanical thrombectomy
primarily affected CBF, as measured by the long source-detector separation, which is
consistent with the underlying vascular anatomy and supports the notion that long DCS
source-detector separations are primarily affected by cerebral tissue. In future studies,
multi-layer approaches for DCS/DOS can and should be used to more carefully separate
intracerebral and extracerebral blood flow changes (see Chapter 5 and [20, 166–172]).
Calibration of CBF indices recovered from DCS would enable absolute comparison of
CBF across subjects [23, 117, 141], but this is unlikely to affect the relative flow reported
in this study if not coupled to multi-layer models.
4.4 Conclusions
We have demonstrated the feasibility of real-time monitoring of cerebral hemodynamics
during mechanical thrombectomy. By measuring the frontal lobe microvascular hemody-
namics with diffuse optics, it was possible to observe distinct perfusion profiles in two
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patients with divergent clinical outcomes. Although future studies in larger populations
are clearly needed to better delineate application opportunities for DCS/DOS optical
hemodynamic monitoring during mechanical thrombectomy, this pilot demonstration of
diffuse optics shows promise for assessing the response to endovascular treatment and for
guiding physiology-based therapy in this and other contexts.
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Chapter 5
Improvement of the optical parameters
recovered from diffuse optical
spectroscopies
In Chapters 3 and 4, we employed a semi-infinite (SI) homogeneous model to recover the
cerebral hemodynamics of neurocritical patients. However, as previously highlighted, the
SI assumption may lead to erroneous interpretation of the cerebral physiology, as diffuse
optical measurements are contaminated by extra-cerebral physiology. In this chapter, we
propose the implementation of an improved model to recover the absorption and flow
changes. More specifically, we propose the application of a two-layer model that attempts
to separate the contributions from the extra-cerebral tissues (mainly scalp and skull) from
the cerebral tissues. To test our two-layer model algorithm, we generated data in three
different controlled environments: 1) forward-model simulations with noise; 2) simulations
using the finite-elements method, and; 3) phantom experiments.
5.1 The two-layer model
We decided to use the two-layer model for a cylinder [53, 168–170, 191] as it is more
computationally robust then the standard two-layer solution for a laterally unbounded
medium [53, 170]. Specifically, we modeled the tissue as an infinitely thick cylinder
with radius a, composed of two layers: a first layer with thickness `, representing the
extra-cerebral tissues, and; a second infinitely thick layer, representing the cerebral tissue
(Figure 5.1). Although we restricted our discussion to the FD-DOS and DCS solutions,
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our results can be extended for time-domain measurements with a Fourier-transform of
the solution presented below.
Briefly, by solving the FD-DOS diffusion equation (Equation 2.7) for the two-layer
cylinder depicted in Figure 5.1, it is possible to show that the fluence in the k-th layer,
Φk, can be written as [191]:
Φk(~r, ω) =
∞∑
n=1
Gk(sn, z, ω)J0(snρ)J
−2
1 (a
′sn), (5.1)
where Jn are the Bessel functions of first kind and order n, sn are positive roots of the
0-order Bessel function of first kind divided by a′ = a + zb (i.e., J0(a′sn) = 0), with
zb = 2D1(1 +Reff )/(1−Reff ), and Reff is the fraction of photons that are internally dif-
fusely reflected at the cylinder boundary. Since we generally measure using the reflection
geometry (Figure 2.1), we are only interested in the fluence at the first layer, Φ1. In this
case, G1 is defined as:
G1(sn, z, ω) =
exp (−α1|z − z0|)− exp (−α1(z + z0 + 2zb))
2D1α1
+
sinh (α1(z0 + zb)) sinh (α1(z + zb))
D1α1 exp (α1(`+ zb))
× D1α1 −D2α2
D1α1 cosh (α1(`+ zb)) +D2α2 sinh (α1(`+ zb))
,
(5.2)
where αk =
√
vµak
Dk
+ s2n +
iω
Dk
and z0 = 1/µ′s1. Note that here we assumed that each layer
have the same refractive index. To compute the diffusely reflected intensity (R), we used
Fick’s Law [53, 170]:
R(~r) = D1
∂
∂z
Φ1(~r, ω)
∣∣∣∣
z=0
. (5.3)
Finally, we can compute the theoretical amplitude (ACTheo) and phase (ΘTheo) with:
ACTheo = |R(~r)|
ΘTheo = arg [R(~r)] .
(5.4)
Last, we can show that the DCS solution for a two-layer infinitely thick cylinder is
formally identical to Equations 5.1 and 5.2, but with a different αk:
αk =
√
vµak
Dk
+ s2n +
µ′skk
2
0Fk
3Dk
τ , (5.5)
where k0 = 2pi/λ and Fk is the flow index in the kth layer. Note that the DCS solution
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Figure 5.1: Pictorial representation of the two-layer geometry. We modelled the tissue
as an infinitely thick cylinder with radius a, composed of two layers: a first layer with
thickness `, representing the extra-cerebral tissues, and; a second infinitely thick layer,
representing the cerebral tissue. Each layer have different optical properties (µai, µ′si) and
flow (Fi) .
depends in each layer’s optical properties (µa1, µa2, µ′s1 and µ′s2) as well as the flow in
each layer (F1 and F2).
5.2 Methods
5.2.1 The fitting algorithm
To recover the optical properties of each layer from the FD-DOS data, we used a global
optimizer implemented in Matlab (fmincon), which we found to be the algorithm less
sensitive to the initial conditions. We attempted to minimize the following cost function,
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assuming N source-detector separations:
χ2 =χ2AC + χ
2
Θ
χ2 =
N∑
i=2
[
log
(
ACTheo(ρi)
ACTheo(ρ1)
)
− log
(
ACMeas(ρi)
ACMeas(ρ1)
)]2
+
N∑
i=2
[(ΘTheo(ρi)−ΘTheo(ρ1))− (ΘMeas(ρi)−ΘMeas(ρ1))]2 ,
(5.6)
where ACMeas and ΘMeas are the measured amplitude and phase, respectively, and ACTheo
and ΘTheo are the theoretical values from Equation 5.4. Here, we used the shortest source-
detector separation (i = 1) as the amplitude and phase reference to avoid the necessity
of computing two additional scaling factors. Additionally, since the amplitude decreases
approximately exponentially with increasing source-detector separation, we opted to min-
imize the difference of the logarithm of the amplitude to reduce any potential biases to
the shorter source-detector separations.
To better constraint our algorithm, we bounded the minimization algorithm between
0.01 ≤ µai(cm−1) ≤ 0.4 and 4 ≤ µ′si(cm−1) ≤ 15, where i = 1, 2 refers to the first and
second layers, respectively. These limits were based on the expected values for the optical
coefficients of an adult head [62]. Also, we assumed prior knowledge of the first layer
thickness (`) to recover the optical properties of each layer. Note that this assumption is
not a limitation for neurocritical patients, as in these patients we will always have access
to at least one type of structural brain imaging (such as CT or MRI), allowing direct
measures of `.
To recover the flow indexes (F1 and F2) from the DCS data, we minimized the squared
difference of the theoretical and experimental auto-correlation functions, i.e.:
χ2DCS =
∑
τi
(
g
(Theo)
2 (τi)− g(Meas)2 (τi)
)2
. (5.7)
In our fitting algorithm, we restricted the minimization algorithm to delay times in which
g2(τ) ≥ 1.1. To compute β from Siegert’s relation [125], we used a SI model to fit the
early portion of the auto-correlation curves (i.e., g2(τ) > 1.2), separately for each source-
detector separation. In the DCS computations, we used the optical properties recovered
with either a SI or two-layer model of the FD-DOS data, and we bounded our fitting
algorithm to recover flow in the range 0.001 ≤ Fi(10−8cm2/s) ≤ 1000, where i = 1, 2
refers to the first and second layers, respectively.
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5.2.2 Forward-model simulations
To test the efficacy of our two-layer algorithm, we first generated data using the forward-
model with varying optical properties. We randomly generated 150 curves with µa1 and
µa2 varying between 0.05 and 0.2cm−1, and µ′s1 and µ′s2 varying between 7 and 12 cm−1.
We repeated the simulation three times, with different levels of noise, to simulate the
experimental noise: 1) without noise; 2) 1% amplitude noise and 0.05o phase noise, and; 3)
2% amplitude noise and 0.1o phase noise. Note that in common experimental conditions,
we expect approximately 2% amplitude noise and 0.1o phase noise [170]. We generated
amplitude and phase data for 20 source-detectors separations, equally divided between
0.8 and 4.6 cm.
5.2.3 Simulation using a finite-elements package
To test our algorithm in a more realistic scenario, we used an open-source package that
uses the finite-elements method to simulate diffuse optical spectroscopy data (NIRFAST)
[192, 193]. With this package, we generated a two-layered cube, with dimensions 20 ×
15× 15cm and with a node size of 0.15cm. This was a compromise between the precision
and the run-time of the simulation. We varied the absorption coefficient of the second
layer (µa2) between 0.08 and 0.17cm−1, in steps of 0.01 cm−1, with a fixed absorption
coefficient in the first layer (µa1 = 0.1cm−1) and with fixed scattering coefficients in both
layers (µ′s1 = µ′s2 = 8cm−1). We repeated the simulation three times, with different
first layer thicknesses: ` = 0.8, 1.2 and 1.4 cm. Here, we also generated amplitude
and phase data for 20 source-detectors separations, equally divided between 0.8 and 4.6
cm. However, to better match experimental conditions, we restricted our analysis to two
different representative sets of 8 source-detector separations:
ρLong = 0.8, 1.2, 1.6, 2.0, 2.8, 3.2, 3.6, 4.0 cm,
ρShort = 0.8, 1.2, 1.4, 1.8, 2.0, 2.2, 2.4, 3.0 cm.
(5.8)
5.2.4 Phantom measurements
To test our algorithm in a real environment, we also conducted a two-layer liquid phantom
experiment. We developed a black acrylic aquarium capable of mimicking a two-layer
geometry (Figure 5.2-A). To separate each layer, we used a thin plastic film attached to
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a black frame, and we used silicon glue to seal the frame edges. We have also attached a
peristaltic pump to the aquarium, to induce flow changes in the second layer. To attach
the optical fibers, we have drilled holes in one side of the phantom, such that the fibers
were directly in contact with the liquid. The phantom allowed measurements with FD-
DOS with 8 different source-detector separations (0.7, 1.2, 1.5, 1.7, 2.0, 2.2, 2.5, 3.0 cm),
and DCS with 4 source-detector separations (0.8, 1.5, 2 and 2.5 cm). To avoid saturation
of the shorter source-detector separations, we glued neutral-density filters in some of the
optical fiber positions. In this experiment, we used the hybrid optical system developed
at UNICAMP (see Section 3.1.3 for more details).
To calibrate the expected optical properties, we first conducted a semi-infinite mea-
surement (i.e., without the thin plastic film). To this end, we used an initial solution
composed of 4500ml of distilled water, 200ml of Liponfundin 20% and 2ml of an ink so-
lution. The ink solution was composed of 0.5 ml of ink (Nankin, Acrilex) and 25ml of
water. Then, we varied the absorption of the medium by multiple additions of 0.5ml of
the ink solution.
For the two-layer experiment (Figure 5.2-B), we used a starting solution with the
same initial concentrations used in the semi-infinite experiment. We fixed the first-layer
thickness at ` = 1.2 cm and varied the absorption of the second-layer by adding 0.5ml
of a similar ink solution. In the two-layer experiment, after each addition of ink, we also
changed the flow in the second layer by changing the flow output of the peristaltic pump,
which was capable of outputting a maximum of 3L/min. After each flow and absorption
change, we waited at least 6 minutes for the solution to stabilize.
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Figure 5.2: Experimental setup for the phantom measurements. (A) We used the system
developed at UNICAMP (see Chapter 3), and developed a black acrylic aquarium capable
of mimicking a two-layer geometry. In our two-layer experiment, we started with an initial
solution composed of 4500ml of water, 200ml of a lipid emulsion (Lipofundin 20%), and
2ml of an ink solution (0.5 ml of ink and 25ml of water). (B) To simulate changes in the
second layer, We varied the absorption by multiple additions of 0.5ml of the ink solution.
After each ink addition, we have also changed the flow in the second layer by changing
the flow output of a peristaltic pump. We repeated this process nine times.
5.3 Results
5.3.1 Forward-model
First, we tested our two-layer algorithm with the forward-model generated data (Sec-
tion 5.2.2). For the simulations without noise, the algorithm was capable of precisely
recovering all four optical coefficients (green points in Figure 5.3). However, when we
tried to recover the optical properties in the two datasets with noise, we were unable to
recover the scattering coefficient of the second layer (µ′s2), independently of the noise level.
However, the errors on µ′s2 did not seem to affect the accuracy in the recovery of the other
three parameters: we were able to recover the absorption coefficient of both layers (µa1
and µa2), as well as the scattering coefficient of the first layer (µ′s1).
To understand our inability to recover the scattering of the second layer, we generated
several amplitude and phase curves for a medium with ` = 1.2 cm, with varying µ′s2
(between 5 and 15 cm−1), but fixed µ′a1 = 0.1cm−1, µa2 = 0.14cm−1 and µ′s1 = 8cm−1.
As seen in Figure 5.4, even though we varied the scattering coefficient of the second layer
across a wide range, we encountered minimal differences in the amplitude and phase values
with source-detector separations up to 4.6 cm. Notably, the differences due to changes
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Figure 5.3: Results of the forward model simulations. Our two-layer algorithm was capable
of recovering the (A) absorption coefficient in the first, (B) the absorption coefficient in
the second layer, as well as the (C) scattering coefficient of the first layer, independently
of the noise level. However, although we were able to recover the (D) scattering coefficient
of the second layer for the case without noise, we were unable to accurately recover µ′s2
for the simulations with noise. Note that the errors on µ′s2 did not seem to affect our
accuracy in the recovery of the other three parameters.
in µ′s2 were on the same order of the expected noise. Since we are not sensitive to the
scattering coefficient of the second layer (µ′s2), we assumed that the scattering coefficients
of the first and second layers are equal (i.e., µ′s1 = µ′s2 = µ′s). This assumption, although
arbitrary, improves the recovery of optical properties as it allows our algorithm to fit for
one less parameter. Note that we do not expect errors in µ′s2 to affect the recovery of the
other parameters (Figure 5.3).
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Figure 5.4: Theoretical (A) amplitude (ACTheo) and (B) phase (ΘTheo) values simulated
for source-detector separations between 0.8 and 4.6cm. We varied scattering coefficient in
the second layer (µ′s2) between 5 and 15 cm−1, and fixed the absorption coefficient at 0.1
cm−1 and 0.14 cm−1, for the first second layers, respectively. We also fixed the scattering
coefficient of the first layer at 8 cm−1, and the first layer thickness was 1.2 cm.
5.3.2 Simulation using a finite-elements package
To further test our algorithm, we also tried to recover the optical properties in a set of
simulations using the NIRFAST package. To quantify the recovery error on each optical
parameter, we calculated the relative error, which is defined as:
Relative Error =
XMeas −XExpected
XExpected
, (5.9)
where XMeas and XExpected are the measured and expected optical coefficients. First,
we attempted to recover the optical properties using the shorter set of source-detector
separations, ρShort (Equation 5.8). In this case, we were able to recover all three optical
properties, for all three layer thicknesses, with relative error of approximately: −0.4% for
µa1, −10.6% for µa2, and 6.2% for µ′s (Figure 5.5). When using the longer source-detector
separations (ρLong), we were able to recover slightly better results for the absorption in the
second layer, for all three layer thicknesses, with relative errors of approximately −8.5%
for µa1, 2.5% for µa2, and 7.6% for µ′s (Figure 5.6).
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Figure 5.5: Results of the NIRFAST simulations with the shorter set of source-detector
separations (ρShort). By assuming that the scattering coefficient of the first and second
layer are equal (µ′s1 = µ′s2 = µ′s), we were able to recover within ∼ 10% of the expected
values (A) the absorption coefficient of the first layer (µa1), (B) the absorption coefficient
of the second layer, as well as (C) the scattering coefficient (µ′s).
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Figure 5.6: Results of the NIRFAST simulations with the longer set of source-detector
separations (ρLong). By assuming that the scattering coefficient of the first and second
layer are equal (µ′s1 = µ′s2 = µ′s), we were able to recover with errors < 10% (A) the
absorption coefficient of the first layer (µa1), (B) the absorption coefficient of the second
layer, as well as (C) the scattering coefficient (µ′s).
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5.3.3 Phantom experiments
Last, we validated our two-layer algorithm to recover the optical properties in a more
realistic experiment using a liquid phantom. In order to recover a single value of µa1, µa2
and µ′s for each step of ink addition, we averaged the amplitude and phase data across
all changes in pump flow. In Figure 5.7, we show the values recovered from the two-
layer model compared to the expected values recovered from the semi-infinite experiment
for the 690 nm wavelength. In agreement with the results from Figure 5.5, that used
similar source-detector separations, we were able to recover all the optical properties of
each layer within 10% of the expected values (Figure 5.7). Although the correct trend in
the absorption values was recovered from the two layer phantom using a SI model, the
absolute values for the second layer were underestimated.
To test the two-layer model for DCS, we also changed the flow in the second layer of
the phantom. In our initial attempt, we tried to recover the flow indexes from each layer
(F1 and F2) using the optical properties recovered by fitting the FD-DOS data with a
SI model, i.e., we assumed that µ(SI)a = µa1 = µa2 and µ
′(SI)
s = µ′s1 = µ
′
s2. We used all
four DCS source-detector separations (0.8, 1.5, 2.0 and 2.5 cm) simultaneously to recover
Figure 5.7: Optical coefficients recovered from the two-layer phantom experiment. By
employing the two-layer model, we recovered the (A) absorption coefficients and (B) scat-
tering coefficients from each layer of our phantom experiment. We accurately recovered
the increasing absorption coefficients in the second layer (µa2, red curve), and a stable ab-
sorption coefficient in the first layer (µa1, green curve), and a stable scattering coefficient.
Note that we assumed an equal scattering coefficients for both layers (µ′s = µ′s1 = µ′s2).
We also show the values recovered using a SI model for the two-layer phantom data (blue
curves). The expected values were calibrated with a SI phantom measurement.
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Figure 5.8: Flow recovered from the two-layer phantom experiment using a two-layer
model for DCS, and a SI model for FD-DOS. We found (A) an increase in the first layer
flow (F1), and (B) a decrease in the second layer flow (F2), with increase absorption for
each pump flow.
the flow indexes. As seen in Figure 5.8, although we expected similar flow across the
different pump states, we measured an increase in F1 and a decrease in F2 with increasing
µa2. Thus, by not properly accounting for the absorption differences between the first and
second layers, we introduced systematic errors in the recovery of the flow indexes.
Then, we tried to fit the DCS data using the two-layer optical properties obtained
with FD-DOS (i.e., µa1, µa2 and µ′s = µ′s1 = µ′s2). To better match common experimental
conditions, we also restricted our fitting algorithm to use only the shortest (0.8 cm) and
longest (2.5 cm) DCS source-detector separations. To reduce the number of parameters
in the two-layer algorithm for DCS, we first recovered the blood flow index of the first
layer (F1) using the shortest DCS separation and the first layer optical properties (µa1
and µ′s) as input to a SI model. For first-layer thicknesses larger than 1 cm, which is the
case for an adult head, a 0.8 cm source-detector separation is only sensitive to the first
layer, and thus a SI model suffices to recover F1. Then, to estimate F2, we used the long
DCS source-detector separation, the F1 recovered from the short DCS separation and the
two-layer optical properties obtained with FD-DOS as input to the two-layer model for
DCS.
With this method, as seen in Figure 5.9-A, we recovered F1 values that were inde-
pendent of the changes in absorption and flow of the second-layer, as expected. Fur-
thermore, we also recovered F2 values that were independent of the absorption changes
in the second-layer (Figure 5.9-B). More precisely, when the pump was at 100%, we ob-
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Figure 5.9: Flow recovered using the two-layer model for both DCS and FD-DOS. We
found (A) a stable flow in the first layer (F1), regardless of the absorption and flow
changes in the second layer. (B) The recovered flow values from the second layer (F2) were
independent of the absorption changes, and were consistent with the expected changes
due to the pump flow changes.
tained F2 = (7.1 ± 0.5) × 10−8cm2/s, while for the pump at 75% we obtained: F2 =
(5.3± 0.3)× 10−8cm2/s. When comparing the values between the pump at 100 and 75%,
we obtained a relative difference in flow of (75± 5)%, as expected. When the pump was
50%, we obtained F2 = (2.3 ± 0.5) × 10−8cm2/s, and encountered a relative change of
(32± 7)%, when comparing with the pump at 100%.
5.4 Discussion and Conclusions
In this study, we validated a two-layer model for FD-DOS to recover the optical properties
in three different controlled environments. First, we showed that FD-DOS measurements
with source-detector separations up to 4.6 cm are not sensitive to the scattering coefficient
of the second layer. Then, by assuming that the scattering coefficients of the first and
second layers are equal, we showed that it is possible to recover the optical properties as
well as the flow indexes from each layer with approximately 10% error. As mentioned
in the previous chapters, in the diffuse optics literature the most common approach for
data analysis has been the SI model. However, as seen in Figure 5.7, the SI assumption
may lead to underestimation of the true changes from the second-layer. Nonetheless,
although the SI model underestimates the changes in the second-layer, a simplistic SI
assumption can still recover the correct trends of physiological changes. Thus, although
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the two-layer model certainly improves the results presented in the previous chapters, it
does not invalidate the results obtained with the SI model.
Unfortunately, we are unable to apply the two-layer method presented in this current
chapter to the results from the previous chapters. To accurately measure the two-layer
optical properties from FD-DOS with a single modulation frequency, we need at least 8
source-detector separations [53, 170], but in Chapter 3 we were restricted to four source-
detector separations for FD-DOS. However, we measured three source-detector separa-
tions for DCS, and thus we could use a two-layer model for the DCS data, but not for
FD-DOS data. To check whether using a two-layer model only for DCS would improve the
accuracy in the recovery of the flow changes, we tested our two-layer algorithm for DCS
using a SI model for FD-DOS. However, as seen in Figure 5.8, this still resulted in the
misinterpretation of absorption changes as flow changes. Thus, to properly improve the
reliability of the diffuse optical measurements of cerebral physiology, we need to account
for the layer differences of both the optical coefficients and the difference in flow.
It is worth noting a few limitations of the study presented in this chapter. First, we
did not simulate data for DCS, as currently this is not implemented in NIRFAST; a DCS
simulation could allow us to estimate the error in the absolute flow estimates. Additionally,
the two-layer model is still not a perfect model, as the extra-cerebral tissues are highly
heterogeneous; for example, we expect different optical properties for the scalp and the
skull [62]. However, more complex models (such as a three-layer model [167, 168]) requires
extra parameters, which will further complicate the recovery algorithms. In future studies,
by simulating a realistic head with NIRFAST it may be possible to estimate the errors
introduced by a heterogeneous first-layer for different models. Nonetheless, although
simplistic, our two-layer approach for DOS and DCS already has the potential to improve
the reliability of cerebral hemodynamic monitoring with diffuse optics over the traditional
SI methods.
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Chapter 6
Summary and Perspectives
The main goal of this work was to show that diffuse optics can aid in real-time monitoring
of cerebrovascular diseases. To this end, we first developed and translated a hybrid
diffuse optical system to a neuro intensive care unit (neuro-ICU) of a public hospital
in Brazil (‘Hospital de Clínicas’, University of Campinas). Our hybrid system combined
FD-DOS and DCS to monitor cerebral oxygenation and cerebral blood flow in real-time.
To facilitate its use by clinical personnel, we developed a user-friendly graphical user
interface based on current clinical monitors already in the neuro-ICU. The pilot study
presented in Chapter 3 showed that diffuse optics may provide supporting information
for monitoring secondary damage in neurocritical patients, with minimal interference
with standard clinical practices. The optically-derived hemodynamic parameters provided
neurophysiological information at the microvasculature level which was consistent with
the patient clinical outcome.
Then, we reported in Chapter 4 a pilot study that demonstrates the feasibility of real-
time monitoring of cerebral blood flow hemodynamics during mechanical thrombectomy.
We reported two cases of patients with internal carotid artery occlusions that underwent
mechanical thrombectomy at the Hospital of the University of Pennsylvania. By mea-
suring the frontal lobe microvascular hemodynamics with diffuse optics, it was possible
to observe distinct reperfusion profiles for patients with divergent clinical outcomes. Our
results suggest that cerebral hemodynamic monitoring with diffuse optics hold potential
for assessing the response to endovascular treatment of stroke. Taken together, the re-
sults from Chapters 3 and 4 showed that diffuse optics is a promising monitoring tool
for guiding physiology-based therapy in neurocritical patients. Thus, the translation of
diffuse optics to clinical settings may positively impact clinical care and patient outcome,
and may be especially useful in low-budget hospitals and in remote areas, where cerebral
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physiology monitoring is essential but not readily available.
Last, we also proposed the implementation of a two-layer model to separate the extra-
cerebral and cerebral contributions to the optical signal. We showed that it is possible to
recover the optical properties and flow from the first and the second layer of our model
(representing the extra-cerebral and cerebral layers, respectively) within ∼10% error.
This is more accurate than what is currently reported in the literature. Additionally, we
showed that a simplistic SI model underestimates the true cerebral changes, and that by
not accounting for the layer differences in the optical properties one may misinterpret
absorption changes as flow changes. This is especially relevant for neurocritical patients,
where the cerebral oxygenation and CBF may be independently changing.
There are few possible steps that could further improve the results presented in this
thesis. First, to show that diffuse optics can positively impact patient outcome, a larger
longitudinal validation study in the clinic is necessary. Here, we focused on case-reports
to assess whether diffuse optics is sensitive to the individual physiology of the patients;
however, no conclusions should be drawn from case-studies. Additionally, the develop-
ment of new optical probes capable of measuring through hair is still lacking. Although
measurements in the forehead may be useful for diseases with a global cerebral response,
a targeted placement of the optical probes over a region of interest may be more informa-
tive. For example, by using a neuro-navigator system, physicians could place the optical
probes directly over the penumbra in ischemic stroke patients, potentially improving the
sensitivity of diffuse optics to the salvageable tissues. By directly measuring the penum-
bra, clinicians could develop specific therapeutic interventions based on the individual’s
physiology, which has the potential to positively impact clinical care and patient outcome.
From the modeling perspective, the two-layer model proposed in Chapter 5 is still a
simplistic approximation, as it does not take into account the heterogeneous structure of
the extra-cerebral tissues. To this end, a comparison of the two-layer model with more
complex models, such as a three-layer model [167] is advisable. However, the increase in
the number of free parameters could decrease the robustness of more complex models.
By simulating realistic head geometries (e.g. using the NIRFAST package) it may be
possible to assess the efficacy of the two-layer model as well as other more complex models.
Additionally, by comparing the results from in vivo diffuse optical studies with other gold-
standard measurements of cerebral hemodynamics (such as ASL), it may be possible to
estimate the experimental uncertainties of the two-layer model [23].
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Appendix A
Description of the clinical scales
Table A.1: Description of the Hunt & Hess grade scale and associated mortality rate [148].
Grade Criteria Mortality rate
I Asymptomatic, mild headache, slight nuchal rigidity 30%
II Moderate to severe headache, nuchal rigidity, no neurologic
deficit other than cranial nerve palsy
40%
III Drowsiness, confusion, mild focal neurologic deficit 50%
IV Stupor, moderate-severe hemiparesis 80%
V Coma, decerebrate posturing 90%
Table A.2: Description of the Fisher grade scale and associated risk of vasospasm [149].
Grade Blood on CT Risk of vasospasm
I No SAH* detected Low (0-21%)
II Diffuse or vertical layer of subarachnoid blood
<1mm thick
Low (0-25%)
III Localized clot and/or vertical layer within the
subarachnoid space >1mm thick
Low to high (23-96%)
IV ICH or IVH with diffuse or no SAH* Low to moderate (0-35%)
*SAH: Subarachnoid hemorrhage; ICH: Intracerebral hemorrhage; IVH: intravertricular
hemorrhage.
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Table A.3: National Institute of Health Stroke Scale (NIHSS) scores and associated stroke
severity [150].
Score Stroke severity
0 No stroke symptoms
1–4 Minor stroke
5–15 Moderate stroke
16–20 Moderate to severe stroke
21–42 Severe stroke
Table A.4: Modified treatment in cerebral ischemia scale grade definition (mTICI) [175,
176].
Grade Definition
0 No perfusion
1 Antegration reperfusion past the initial occlusion, but limited distal
branch filling with little or slow distal reperfusion
2a Antegrade reperfusion of less than half of the previously occluded target
artery ischemic territory
2b Antegrade reperfusion of more than half of the previously occluded target
artery ischemic territory
3 Complete antegrade reperfusion of the previously occluded target artery is-
chemic territory, with absence of visualized occlusion in all distal branches
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	 Você	 está	 sendo	 convidado	 a	 participar	 como	 voluntário	 de	 uma	 pesquisa.	 Este	
documento,	 chamado	 Termo	 de	 Consentimento	 Livre	 e	 Esclarecido,	 visa	 assegurar	 seus	
direitos	como	participante	e	é	elaborado	em	duas	vias,	uma	que	deverá	ficar	com	você	e	outra	
com	o	pesquisador.		
	 Por	 favor,	 leia	 com	 atenção	 e	 calma,	 aproveitando	 para	 esclarecer	 suas	 dúvidas.	 Se	
houver	 perguntas	 antes	 ou	 mesmo	 depois	 de	 assiná-lo,	 você	 poderá	 esclarecê-las	 com	 o	
pesquisador.	Se	preferir,	pode	levar	este	Termo	para	casa	e	consultar	seus	familiares	ou	outras	
pessoas	 antes	 de	 decidir	 participar.	 Não	 haverá	 nenhum	 tipo	 de	 penalização	 ou	 prejuízo	 se	
você	não	aceitar	participar	ou	retirar	sua	autorização	em	qualquer	momento.	
	
Justificativa	e	objetivos:	
	 O	objetivo	geral	deste	projeto	é	avaliar	a	utilidade	de	 técnicas	ópticas	no	Brasil	para	
auxiliar	no	monitoramento	de	pacientes	com	AVC.	Uma	vez	que	estas	 técnicas	 são	novas	na	
realidade	 brasileira,	 tal	 estudo	 se	 faz	 importante	 para	 melhor	 conhecer	 como	 doenças	
cerebrovasculares,	 como	 o	 acidente	 vascular	 cerebral	 (AVC),	 afeta	 o	 funcionamento	 do	
cérebro.	Também	é	 importante	saber	como	estas	novas	técnicas	podem	ajudar	a	melhorar	o	
diagnóstico	 e	 acompanhamento	 de	 pacientes	 após	 serem	 diagnosticados	 com	 alguma	 lesão	
cerebrovascular.		
	 As	técnicas	a	serem	utilizadas	são	conhecidas	como	espectroscopia	óptica	de	difusão	
(DOS)	 e	 espectroscopia	 de	 correlação	de	 difusão	 (DCS).	DOS	 e	DCS	 são	 técnicas	 inofensivas,	
capazes	de	produzir	 informações	sobre	as	mudanças	da	oxigenação	e	do	 fluxo	de	sangue	no	
cérebro	quando	este	interage	com	a	luz	infravermelha	de	forma	portátil	e	não	invasiva.	Nosso	
equipamento	usa	uma	combinação	de	DOS	e	de	DCS.	
	
Procedimentos:	
	 Participando	do	estudo	você	está	sendo	convidado	a	ser	monitorado	com	uma	técnica	
extra	ao	que	 já	se	 faz	clinicamente.	Os	pesquisadores	 irão	trazer	um	equipamento	óptico	de	
DOS/DCS	até	o	seu	leito,	e	colocarão	um	sensor	óptico	sobre	a	sua	cabeça.	Este	sensor	contém	
fibras	 ópticas,	 que	 serão	 posicionadas	 para	 iluminar	 e/ou	 coletar	 a	 luz	 infravermelha.	 A	
potência	e	o	comprimento	de	onda	da	luz	incidente	não	produzem	riscos	para	você.	A	coleta	
de	dados	durará	entre	2	horas	e	8	horas,	dependendo	do	seu	diagnóstico	inicial	e	prognóstico	
de	melhora	durante	o	período	de	internação.	Durante	este	período	você	não	estará	restrito	a	
nada,	seguindo	o	tratamento	normalmente.	Este	procedimento	poderá	se	repetir	todos	os	dias	
durante	a	sua	hospitalização,	até	o	dia	de	você	ir	embora.		
	 Durante	 a	 realização	 do	 exame	 você	 estará	 acompanhado	 pelos	 pesquisadores,	 que	
passarão	 informações	 detalhadas	 e	 esclarecerão	 as	 suas	 dúvidas	 a	 respeito	 de	 cada	
procedimento.	 Caso	 você	 se	 sinta	 desconfortável,	 pode	 pedir	 para	 encerrar	 o	 estudo	 a	
qualquer	momento,	 em	qualquer	 dia.	Neste	 caso,	 a	 sua	 participação	 será	 interrompida	 sem	
qualquer	penalidade.	Seu	tratamento	no	hospital	não	será	prejudicado	de	forma	alguma.		
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Desconfortos	e	riscos:	
	 As	técnicas	de	DOS	e	DCS	tem	sido	utilizadas	desde	o	início	da	década	de	1990	como	
instrumento	 de	 pesquisa,	 incluindo	 pacientes	 com	 distúrbios	 e	 doenças	 neurológicos,	 sem	
nenhum	 risco	 determinado.	 Não	 há	 riscos	 previsíveis	 da	 técnica,	 pois	 a	 potência	 da	 luz	
utilizada	é	muito	baixa	para	produzir	algum	dano	no	tecido.		
Quanto	aos	desconfortos,	 você	poderá	 sentir	um	pouco	a	pressão	das	 fibras	 sobre	a	
sua	 cabeça.	 O	 procedimento	 é	 minucioso	 e	 o	 uso	 do	 arranjo	 pode	 causar	 um	 certo	
desconforto.	 Por	 este	 motivo,	 o	 sensor	 óptico	 será	 reposicionado	 a	 cada	 2	 horas.	 Caso	 o	
desconforto	seja	grande,	você	poderá	avisar	aos	pesquisadores	e	eles	reposicionarão	o	arranjo	
para	melhorar	o	conforto	antes	deste	período.		
	
Benefícios:	
	 Você	 não	 obterá	 nenhuma	 vantagem	 direta	 com	 a	 sua	 participação	 nesse	 estudo.	
Contudo,	os	resultados	da	pesquisa	podem,	a	longo	prazo,	trazer	melhorias	nos	diagnósticos	e	
tratamentos	clínicos	com	DOS/DCS	para	pacientes	com	doenças	cerebrovasculares,	na	mesma	
situação	que	a	 sua.	Os	 resultados	do	 seu	exame	de	DOS/DCS	 ficarão	à	disposição	 caso	 você	
e/ou	seu	médico	queiram	saber	os	resultados	no	futuro.		
	
Sigilo	e	privacidade:	
	 Você	 tem	 a	 garantia	 de	 que	 sua	 identidade	 será	 mantida	 em	 sigilo	 e	 nenhuma	
informação	será	dada	a	outras	pessoas	que	não	façam	parte	da	equipe	de	pesquisadores.	Na	
divulgação	dos	 resultados	desse	estudo,	 seu	nome	não	 será	citado.	Os	 resultados	do	estudo	
poderão	fazer	parte	do	prontuário	médico,	mesmo	que	retrospectivo.	
	
Ressarcimento	e	Indenização:	
Você	não	será	reembolsado	pela	sua	participação	na	pesquisa,	uma	vez	que	a	mesma	
não	vai	gerar	nenhum	gasto.	Você	terá	a	garantia	ao	direito	a	indenização	diante	de	eventuais	
danos	decorrentes	da	pesquisa.	
	
Contato:	
Em	 caso	 de	 dúvidas	 sobre	 a	 pesquisa,	 você	 poderá	 entrar	 em	 contato	 com	 os	
pesquisadores	 Rickson	 Coelho	 Mesquita,	 no	 Laboratório	 de	 Física	 Médica	 do	 Hospital	 das	
Clínicas	da	UNICAMP,	na	Rua	Tessália	Vieira	de	Camargo,	126,	telefone	(19)	3521-0137,	e-mail:	
rickson@ifi.unicamp.br,	 ou	 com	 Marilise	 Katsurayama,	 no	 Departamento	 de	 Neurologia	 do	
Hospital	das	Clínicas	da	UNICAMP,	na	Rua	Tessália	Vieira	de	Camargo,	126,	telefone	(19)	3521-
7489,	e-mail:	marilise_k@hotmail.com 
Em	caso	de	denúncias	ou	reclamações	sobre	sua	participação	e	sobre	questões	éticas	do	
estudo,	você	poderá	entrar	em	contato	com	a	secretaria	do	Comitê	de	Ética	em	Pesquisa	(CEP)	
da	 UNICAMP	 das	 08:30hs	 às	 11:30hs	 e	 das	 13:00hs	 as	 17:00hs	 na	 Rua:	 Tessália	 Vieira	 de	
Camargo,	126;	CEP	13083-887	Campinas	–	SP;	telefone	(19)	3521-8936	ou	(19)	3521-7187;	e-
mail:	cep@fcm.unicamp.br.	
	
O	Comitê	de	Ética	em	Pesquisa	(CEP).			
O	 papel	 do	 CEP	 é	 avaliar	 e	 acompanhar	 os	 aspectos	 éticos	 de	 todas	 as	 pesquisas	
envolvendo	 seres	 humanos.	 A	 Comissão	 Nacional	 de	 Ética	 em	 Pesquisa	 (CONEP),	 tem	 por	
objetivo	 desenvolver	 a	 regulamentação	 sobre	 proteção	 dos	 seres	 humanos	 envolvidos	 nas	
pesquisas.	 Desempenha	 um	 papel	 coordenador	 da	 rede	 de	 Comitês	 de	 Ética	 em	 Pesquisa	
(CEPs)	 das	 instituições,	 além	 de	 assumir	 a	 função	 de	 órgão	 consultor	 na	 área	 de	 ética	 em	
pesquisas.	
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Consentimento	livre	e	esclarecido:	
Após	ter	recebido	esclarecimentos	sobre	a	natureza	da	pesquisa,	seus	objetivos,	métodos,	
benefícios	previstos,	potenciais	riscos	e	o	incômodo	que	esta	possa	acarretar,	aceito	participar	
e	declaro	estar	recebendo	uma	via	original	deste	documento	assinada	pelo	pesquisador	e	por	
mim,	tendo	todas	as	folhas	por	nós	rubricadas:	
	
Nome	do	(a)	participante:	________________________________________________________	
Contato	telefônico:	_____________________________________________________________		
e-mail	(opcional):	______________________________________________________________	
	
_______________________________________________________	Data:	____/_____/______.	
	(Assinatura	do	participante	ou	nome	e	assinatura	do	seu	RESPONSÁVEL	LEGAL)		
	
	
Responsabilidade	do	Pesquisador:	
Asseguro	 ter	 cumprido	 as	 exigências	 da	 resolução	 466/2012	 CNS/MS	 e	
complementares	na	elaboração	do	protocolo	e	na	obtenção	deste	Termo	de	Consentimento	
Livre	e	Esclarecido.	Asseguro,	também,	ter	explicado	e	fornecido	uma	via	deste	documento	ao	
participante.	 Informo	 que	 o	 estudo	 foi	 aprovado	 pelo	 CEP	 perante	 o	 qual	 o	 projeto	 foi	
apresentado.	 Comprometo-me	 a	 utilizar	 o	 material	 e	 os	 dados	 obtidos	 nesta	 pesquisa	
exclusivamente	para	as	finalidades	previstas	neste	documento	ou	conforme	o	consentimento	
dado	pelo	participante.	
	
______________________________________________________	Data:	____/_____/______.	
(Assinatura	do	pesquisador)	
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